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Abstract 
PURPOSE: To determine if a 12-week program designed to increase breaks in 
sedentary time will improve blood glucose control compared to a standard 12-week 
walking program for patients with Type II Diabetes. METHODS: 19 participants (ages 
40-64) were randomized into a Breaks Group (BG) or a Walking Group (WG) for the 
12 week intervention. The BG was asked to take 2-minute breaks every hour of 
sedentary time and the WG was asked to increase their walking to 10,000 steps per day, 
including at least 30 minutes of moderate-vigorous physical activity (PA) in chunks of 
at least 10 minutes. Physical activity, sedentary time, and breaks were measured pre- 
and post-intervention using minutes of moderate-vigorous PA (Actigraph GT1M 
accelerometers) and steps were also measured (Yamax SW200 pedometers). Blood 
glucose and Hemoglobin A1C levels were measured pre- and post-intervention. 
Researchers maintained minimal contact with participants during the intervention 
through weekly emails and bi-weekly phone calls. Analysis of Variance with repeated 
measures was used to make comparisons (p < 0.05). RESULTS: 12 participants 
completed all measurements. Moderate-vigorous PA increased over time (16.7 minutes 
per day, p = 0.043), along with a decrease in Hemoglobin A1C (1.6%, p = 0.033). 
Pedometer steps increased while sedentary time and fasting blood glucose decreased, 
but not significantly. There were no differences between groups. CONCLUSION: Both 
interventions resulted in improvement in moderate-vigorous PA and Hemoglobin A1C 
levels in adults with Type II Diabetes, however, no differences were observed between 
groups. The small sample size likely contributed to the inability to obtain significant 
xv 
results and future studies should include a larger sample size and incentives to promote 
compliance.   
1 
Chapter I: Introduction 
Type II diabetes mellitus (T2DM) is a major concern in the United States and 
represents 90-95% of all cases of diabetes.
1
 Due to a lack of initial symptoms, T2DM 
often goes unnoticed by those at high risk or in early stages of the disease. In 2010, 
almost two million adults over age 20 were diagnosed with diabetes and millions more 
were identified as pre-diabetic or exhibited multiple risk factors for the disease.
2
 
Hundreds of billions of dollars are spent each year in the U.S. on indirect and direct 
costs related to diabetes.
2
 If diabetes is left untreated, the vascular system and multiple 
organ systems are damaged and eventually lose their functions. Subsequently, people 
diagnosed with diabetes have twice the risk of stroke or heart attack compared to those 
who do not have diabetes.
1
 Finding an effective prevention and treatment method for 
T2DM will result in significant health and financial benefits for individuals and our 
society.  
Many factors contribute to T2DM risk. These risk factors can and should be the 
targets of intervention. The American Diabetes Association (ADA) has listed several 
risk factors for T2DM: impaired glucose tolerance (IGT) and/or impaired fasting 
glucose (IFG), 45+ years of age, a family history of diabetes, overweight and obesity 
status, physical inactivity, low HDL cholesterol and/or high triglycerides, high blood 
pressure, certain racial and ethnic group membership, and women who had gestational 
diabetes or a baby weighing over nine pounds at birth.
1
 Of those risk factors, physical 
inactivity is one that is modifiable and has been the target of much previous research.
3-8
 





Walking is a common form of PA performed by those with T2DM because this 
activity is low impact and can be done anywhere and anytime with relative ease. 
Walking also can be used to satisfy the suggested PA recommendations for people with 
T2DM. Albright et al.
13
 compiled PA recommendations for those with T2DM and 
concluded that on most if not all days of the week an individual should perform low to 
moderate-intensity cardiorespiratory PA (40 – 70% VO2max). This PA should reach at 
least 30 minutes in duration and increase intensity and duration where possible to 70–
90% of VO2max and for up to one hour. In addition, Hordern et al.
14
 recommended that 
persons with T2DM should accumulate a minimum of 210 minutes of moderate 
intensity aerobic PA (55-69% HRmax) or 125 minutes of vigorous intensity aerobic PA 
(70-89% HRmax) per week,while going no more than two consecutive days without 
exercising. Because of the importance of regular PA, walking programs have been 
implemented to test what methods are most effective in increasing PA in order to meet 
the recommendations and improve health among those with T2DM. 
  Pedometer-based walking programs have been widely used as an effective and 
cost-efficient means of helping T2DM patients become more active.
15 
Lengths of these 
programs have ranged from six weeks to 24 weeks, and include study samples that 
average about 25 T2DM patients in each group. Participants in these studies ranged in 
age from 18-89 with an average age of 57. All of these interventions used some type of 
logbook to record daily steps along with the use of theoretically based strategies such as 
goal setting and self-regulation techniques. Group counseling was also used in some 
studies
16-20
 while other programs used one-on-one counseling techniques with a health 
professional.
20-23
 With the exception of one,
23
 all of these programs produced significant 
3 
increases (from 837 to 8,948 more steps per day) in PA in T2DM patients. Use of 
pedometers as a motivational tool is therefore thought to be effective at increasing PA 
in clinical T2DM populations. This increase in PA was subsequently associated with an 
improvement in short-term health outcomes such as blood glucose and Hemoglobin 
A1c.  
Sedentary time has also been linked to several risk factors for T2DM such as 
obesity, cardiovascular disease (CVD), insulin resistance, and metabolic diseases.
24
 
Sedentary time refers to any time spent in activities involving very little or no 
movement and can include sitting during travel time, sitting at work, sitting at a 
computer or TV, or just sitting during leisure time. These activities generally use little 
energy (1-1.5 METs) at or above resting metabolic rate.
25
 One recommendation 
suggests that sitting time should be limited to no more than two hours of discretionary 
time per day and breaks should be taken for every 30 minute block of sedentary time 
(standing up and moving around).
26
 Decreasing sedentary time has been successful as 
part of a walking program designed to increase steps and a program designed to 
increase breaks in sedentary time.
27,28
 Targeting decreased sedentary time in walking 
programs for adults with T2DM is a relatively new research area where more study is 
needed. 
Purposes 
 The primary purposes of the proposed study include examining differences in 
the effect of a 12-week minimal contact walking program (walking group) as compared 
to a 12-week program that targeted increasing the number of breaks in sedentary time 
(breaks only group) on: 
4 
1. increasing PA levels of inactive T2DM patients; 
2. decreasing sedentary time of inactive T2DM patients;  
3. better understanding the association of self-efficacy with PA and sedentary time 
in inactive T2DM patients; and 
4. improving blood glucose control and blood lipids (Total/HDL) in inactive 
T2DM patients. 
Research Questions 
The research questions for this study include: 
 
RQ1: Will there be differences in self-efficacy (exercise, walking, and sedentary 
break) pre- to post-intervention based on participation in a 12-week minimal 
contact walking program as compared to a 12-week breaks only intervention 
in inactive T2DM patients? 
RQ2: Will there be differences in steps/day, minutes in moderate and vigorous 
intensity PA, MET minutes associated with PA, and sedentary time 
measured pre- and post-intervention based on participation in a 12-week 
minimal contact walking program as compared to a 12-week breaks only 
intervention in inactive T2DM patients? 
RQ3: Will there be differences in fasting blood glucose, HbA1c, and fasting blood 
lipid levels (Total/HDL) pre- to post-intervention based on participation in a 
12-week minimal contact walking program as compared to a 12-week breaks 
only intervention in inactive T2DM patients? 
RQ4: If there are significant changes over time in PA and self-efficacy, is self-
efficacy a predictor of changes in PA and sedentary time? 
5 
Research Hypotheses 
The research hypotheses for this study include the following: 
HR1: Participation in a 12-week minimal contact walking program for 12 weeks 
will result in a significantly greater increase in measures of self-efficacy 
(exercise and walking) pre- to post-intervention as compared to a 12-week 
breaks only intervention in inactive T2DM patients, while participation in a 
breaks only intervention will significantly increase measures of sedentary 
break self-efficacy pre- to post-intervention compared to a 12-week minimal 
contact walking program in inactive T2DM patients. 
HR2: Participation in a 12-week minimal contact walking program will result in a 
significantly greater increase in the number of steps/day, minutes in 
moderate and vigorous intensity PA, and MET minutes associated with PA 
compared to a 12-week breaks only intervention in inactive T2DM patients, 
while participation in a breaks only intervention will significantly decrease 
sedentary time pre- to post-intervention compared to a 12-week minimal 
contact walking program in inactive T2DM patients. 
HR3: Participation in a 12-week minimal contact walking program will result in a 
significantly greater decrease in fasting blood glucose, HbA1c, and fasting 
blood lipid levels (Total/HDL) pre- to post-intervention as compared to a 12-
week breaks only intervention in inactive T2DM patients. 
HR4: If there is a significant change in PA and sedentary time from pre-to post-
intervention, exercise and walking self-efficacy will predict changes in PA 
level and sedentary self-efficacy will predict changes in sedentary time. 
6 
Null Hypotheses 
The null hypotheses for this study include the following: 
 
H01: There will be no differences in self-efficacy (exercise, walking, and 
sedentary break) pre- to post-intervention based on participation in a 12-
week minimal contact walking program as compared to a 12-week breaks 
only intervention in inactive T2DM patients. 
H02: There will be no differences in steps/day, minutes in moderate and vigorous 
intensity PA, MET minutes associated with PA, or sedentary time measured 
pre- and post-intervention based on participation in a 12-week minimal 
contact walking program as compared to a 12-week breaks only intervention 
in inactive T2DM patients. 
H03: There will be no differences in fasting blood glucose, HbA1c, and fasting 
blood lipid levels (Total/HDL) pre- to post-intervention based on 
participation in a 12-week minimal contact walking program as compared to 
a 12-week breaks only intervention in inactive T2DM patients. 
H04: If there are significant changes over time in PA and self-efficacy, self-
efficacy will not be a predictor of changes in PA and sedentary time? 
Significance of Study 
 This study was meaningful because it was the first to test the possible effect of 
an intervention that was designed to break up sedentary time in patients with T2DM 
compared to a “standard care” intervention (i.e. walking). A one-week feasibility study 
has been conducted to increase breaks in sedentary time, but this study assessed 
feasibility and impact of a three-month intervention with breaks assigned throughout the 
7 
entire day for all sedentary time. Implications from this study could help guide future 
interventions focused on decreasing sedentary time in a manner more suitable to 
participants and/or allowing for additional options to intervene beyond a standard 
walking program. 
Delimitations 
Delimitations for this study include: 
1. Participants were adults 40 to 64 years of age who were diagnosed with T2DM. 
2. Participants were currently living in or around the Norman/Oklahoma City, 
Oklahoma area. 
3. Adults unable to walk regularly per physician determination were excluded from 
the study. Each participant was required to provide a Medical Clearance Form 
that was signed by a physician in order to participate. 
4. Adults with bone or joint problems that potentially could be exacerbated by 
increased physical activity were excluded from the study. 
5. Adults who have experienced dizziness or chest pain while participating in 
physical activity were excluded from the study. 
6. Adults taking insulin were excluded from the study, but the use of other 
hypoglycemic medications was permitted. 
7. Adults with diabetic complications (e.g., cardiovascular disease, stroke, heart 
attack) that would make walking unsafe were excluded. 
8. Females who were pregnant or planning to become pregnant were excluded 
from the study. 
9. Adults with a pacemaker were excluded from the study. 
8 
10. Adults that were already part of an exercise group or who were exercising more 
than 30 minutes/day on at least five days/week were excluded from the study. 
11. The intervention (walking and breaks only groups) was administered during 
winter and spring months. 
Limitations 
Limitations for this study include: 
 
1. The pedometer is not accurate at measuring cycling or water activities; 
therefore, those activities were not included in daily step counts.  
2. Participants were volunteers and, therefore, may not be representative of the 
general T2DM adult population. 
3. A “no-intervention” comparison group was not included in this study. Instead, 
as is common in clinical research, the group of the intervention that reflects 
standard practice (walking) was used as the comparison condition. Because of 
this, treatment effects cannot be exclusively attributed to the intervention. 
4. Most participants were affiliated with the University of Oklahoma and, 
therefore, likely had a higher than average education status as compared to the 
general population. 
Assumptions 
Assumptions of the current study include: 
 
1. All participants answered the surveys honestly and accurately. 
2. All participants measured and recorded their pedometer steps on a log sheet 
honestly and according to the study protocol. 
9 
3. All participants were in a fasted state for all study-related blood tests. 
4. All participants consistently followed the protocols for the walking and breaks 
only groups. 
5. All participants took their medications according to the prescription reported at 
baseline and/or reported any usage changes that occurred during the study. 
Operational Definitions 
Operational definitions for this study include: 
1. Accelerometer – Device used to measure body movements in terms of 
acceleration. They can be used to estimate intensity of physical activity over 
time. Accelerometers use piezoelectric sensors to detect accelerations in one or 
more directions (only the vertical direction in this study).
29
  
2. Exercise – Planned, structured, repetitive bodily movement designed specifically 
to maintain or improve bodily fitness.
30
 
3. Pedometer – A device worn on the hip with a spring-loaded lever arm that 
moves vertically with accelerations of the hip when a step is taken. With each 
step, the lever arm contacts a sensor that records the action as one step.
31
  
4. Physical Activity – Any bodily movement using the skeletal muscles that results 
in energy expenditure.
30
 This is operationalized using daily step counts using a 
pedometer and activity counts from an accelerometer summed into 15-second 
intervals and accumulated throughout the day. Water activities and other 
activities that do not cause the hips to move significantly are not captured using 
the pedometer. 
10 
5. Sedentary Behavior – Any activity involving little or no physical activity, such 
as riding in a car, working at a desk, eating a meal at a table, playing video 
games, using a computer, and watching television.
32
 This will be operationalized 
by collecting hours of very low movement using the accelerometer. 
6. Self-efficacy – The conviction that one can successfully execute the behavior 
required to produce [an] outcome.
33
 An example would be having confidence 





Chapter II: Review of the Literature  
Diabetes 
Types of Diabetes 
Diabetes is a global epidemic that is growing and expected to affect over 366 
million people, 4.4% of world population, by the year 2030.
34
 Diabetes is a metabolic 
disease involving the body’s inability to adequately process glucose due either to a 
dysfunction in the insulin receptors or to destruction of the cells that produce insulin in 
the pancreas. Type I Diabetes requires supplemental insulin and occurs when the beta 
cells of the pancreas are targeted and destroyed by the immune system while Type II 
Diabetes (T2DM) is non-insulin dependent and occurs as the cell receptors for insulin 
become desensitized and nonresponsive to insulin. Gestational Diabetes is glucose 
intolerance that occurs during pregnancy and increases a woman’s likelihood of 
developing T2DM in the next 10-20 years by 35-60%.
2
 Of the three main types of 
diabetes, Type II is by far the most prevalent in the United States, accounting for 90-95 
percent of diagnosed diabetes cases.
2
     
Demographics of Type II Diabetes 
The increased prevalence of T2DM has created a health and financial strain; 1.9 
million new cases were identified in 2010 for adults age 20 and older in the United 
States.
2
 Diabetes is expected to be increasingly concentrated in urban areas and spread 
to developing countries.
35
 Slightly more men (13 million) are diagnosed with diabetes 
in the United States compared to women (12.6 million); the prevalence of T2DM 
increases in older populations.
2
 The economic cost of diabetes in 2012 for the United 




 As T2DM advances, serious medical conditions begin to 
develop and if left untreated can lead to disability and death. 
Effects of Type II Diabetes 
All of the systems of the body that receive blood can be negatively affected by 
the high glucose levels which occur under diabetic conditions. Some of these 
complications include nephropathy, neuropathy, blindness, amputations, and 
cardiovascular disease (CVD). Diabetes is the leading cause of kidney failure 
(nephropathy) which is one effect of the high blood sugar levels which damage the 
small blood vessels in the kidneys. As the kidney damage advances, filtration of the 
blood becomes ineffective causing proteins and blood cells leaking into the urine. 
Kidney failure results in a need for dialysis or kidney transplantation. Nerve damage 
(neuropathy) is caused as the nerves are unable to get sufficient blood flow due to 
damage to the blood vessels that supply blood to them. Just like kidney damage, the 
blood vessel damage is caused at least in part by the high blood sugar levels. As nerve 
damage progresses the organs activated by those nerves eventually lose sensation and 
function. Nerve damage along with damage to blood vessels causes an inability for the 
tissues to heal and function properly. This is the major factor in leading to amputation 
of limbs. Diabetes is also a major cause of CVD due to the blood vessel damage caused 
by high blood sugar levels. Those with diabetes are at twice the risk of a stroke or heart 
attack compared to those without diabetes.
1
 
Determinants of Type II Diabetes 
Understanding the determinants of T2DM and how to affect them is important to 
decrease risk for and complications of T2DM. The more risk factors a person has, the 
13 
more likely they are to be diagnosed with T2DM. The American Diabetes Association 
lists eight factors that have been associated with T2DM: people with impaired glucose 
tolerance (IGT) and/or impaired fasting glucose (IFG), people over age 45, people with 
a family history of diabetes, people who are considered overweight or obese, people 
who do not exercise regularly, people with low HDL cholesterol and/or high 
triglycerides, people with high blood pressure, people of certain racial/ethnic groups 
(e.g., Non-Hispanic Blacks, Hispanic/Latino Americans, Asian Americans and Pacific 
Islanders, and American Indians and Alaska Natives), and women who have had 
Gestational Diabetes, or who have had a baby weighing nine pounds or more at birth. 
With each additional risk factor, the likelihood for developing T2DM is increased.  
Type II Diabetes Interventions 
Several methods are currently used to prevent and treat T2DM including: 
education, medical nutrition therapy, physical activity, oral hypoglycemic agents, and 
insulin.
37
 Education, nutrition, and physical activity (PA) are fundamental treatments 
that should be the focus of early treatment and should be individualized to each 
patient.
38
 Standards for diabetes education suggest that certain topics be covered in a 
diabetes education program: (1) disease process; (2) treatment options; (3) nutritional 
plans; (4) exercise plans; (5) knowledge of the diabetes medicines prescribed; (6) blood 
glucose monitoring techniques; (7) knowledge of acute and chronic diabetic 
complications; (8) psychosocial issues; and (9) individual strategies to promote health.
39
 
Nutritional interventions usually involve a level of calorie restriction to promote weight 
loss, along with lower consumption of total and saturated fats and processed foods, as 
well as a higher consumption of fiber, whole grains, fruits, and vegetables, which can 
14 
lead to improvement in glycemic control in diabetic patients.
37
 When combining PA 
with a low glycemic diet, one study found no added benefit with the addition of the diet 
component beyond just increasing PA.
40
 However, several other studies have shown 
that the combination of diet and PA can improve glycemic control.
41-43
 Further research 
is needed to better understand what combination of diet and PA can produce efficacious 
results in T2DM patients. 
Physical activity alone, usually in the form of walking, is also widely and 
effectively used as a lifestyle modification for those diagnosed or at risk for 
T2DM.
9,16,19
 As glucose control decreases and the disease progresses, medication (e.g., 
MetFormin) and eventually insulin may be used to control blood sugar levels. Current 
pharmacological methods for treating T2DM are discussed in detail elsewhere,
37
 but 
their purpose is to improve glycemic control by stimulating the beta cells to increase 
insulin secretion, decrease hepatic glucose output, decrease insulin resistance, delay 
glucose absorption, or some combination of those effects. As T2DM advances, it may 
become necessary to administer exogenous insulin to compensate for the inability of the 
pancreas to meet the demand of the body for normal function. Lifestyle interventions 
are, however, the most reasonable solutions for most people in increasing quality of life 
and decreasing risk for and development of T2DM. 
Physical Activity 
Demographics of Physical Activity 
Physical activity is an important target for intervention because a lack of PA is 
among the leading causes of death in the United States.
44
  Inadequate PA, which is 
distinct from sedentary behavior, has long been a serious concern in the U.S. and other 
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developed countries as lifestyles become more sedentary and energy dense foods 
become more prevalent. The 1996 Surgeon General’s report found that at least one 
fourth of U.S. adults acquired no leisure time PA and as people aged their activity level 
decreased.
45
 In 2009, only about half (51%) of adults in the U.S. reported getting more 
than 30 minutes of moderate intensity PA on five or more days of the week, or 20 
minutes or more of vigorous PA on at least three days per week.
46
 Additionally, 23.8% 
of Americans reported not participating in any PA in the last month.
46
   
 These low PA levels have an effect on the health of the nation which increases 
cost of living and decreases quality of life.
47
 In a study with transport and post office 
employees, men who were more physically active had lower mortality rates from heart 
disease than their less active counterparts.
48
 The Harvard Alumni Study showed that 
increased PA is associated with a decrease in all-cause mortality which can in part be 
attributed to the effects of chronic diseases.
49
  
Recommendations for Physical Activity 
Several organizations have observed the trends of physical inactivity and have 
provided guidelines to increase awareness of the amount and type of PA that will 
produce significant health benefits.
45,50,51
 The Surgeon General’s Report on Physical 
Activity and Health summarized the PA recommendations up to the year 1996 by 
recommending “All people over the age of two should accumulate at least 30 minutes of 
endurance-type physical activity, of at least moderate intensity, on most – preferably all 
– days of the week”.
45
 In 2002, the Department of Health and Human Services outlined 
the costs and benefits of PA with a call to action that people of all ages should acquire 
30 minutes of moderate intensity PA on five or more days of the week, which can be 
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performed in 15- or 10-minute segments.
50
 The report went on to recommend simple 
ways to change, such as promoting a walking program in schools, worksites, or 
communities to meet the recommendations. In a combined report, the American College 
of Sports Medicine and the American Heart Association published PA 
recommendations in 2007 to promote adults between 18 and 65 to get a minimum of 30 
minutes of moderate intensity aerobic PA on five days per week or 20 minutes of 
vigorous aerobic PA on three days per week in bouts of at least 10 minutes.
51
 They also 
recommended that when these minimum recommendations are exceeded there is a 
greater likelihood for preventing chronic disease and disability.        
Physical Activity Effects on People with Type II Diabetes 
Physical activity is important for individuals at all levels of health, but can be 
especially helpful at improving glucose metabolism in those who have been diagnosed 
or are at risk for T2DM. Males with T2DM with low self-reported PA and low 
cardiorespiratory fitness have been shown to be at higher risk for all-cause mortality 
than those who were active or had higher fitness.
52
 Physical activity has also been 
shown to prevent and treat metabolic syndrome which is a group of diseases associated 
with high risk for T2DM and heart disease.
53
 Physical activity recommendations for 
those with T2DM have been established,
13,14
 yet PA is highly neglected among those 
with T2DM.
54-57
 Short and longer-term exercise has been shown to improve insulin 
sensitivity and blood glucose control in patients with T2DM.
3-8
  
Physical activity guidelines have been established and walking is a common 
form of PA for T2DM patients. In a two year counseling intervention, 179 T2DM 
patients were randomized into groups and were tracked over the intervention to assess 
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the overall MET’s per week they achieved through walking. Those who acquired more 
PA had better control of their blood glucose, better physiological and anthropometric 
outcomes, and spent less money on disease-related expenses.
58
 Albright et al. compiled 
PA recommendations for those with T2DM and concluded that on most, if not all, days 
of the week they should perform low to moderate-intensity cardiorespiratory PA (40 – 
70% VO2max) reaching at least 30 minutes in duration and increasing intensity and 
duration where possible to 70–90% of VO2max and for up to one hour.
13
 Hordern et al. 
recommended a minimum of 210 minutes of moderate intensity aerobic PA (55-69% 
HRmax) or 125 minutes of vigorous intensity aerobic PA (70-89% HRmax), and  going no 
more than two consecutive days without exercising.
14
 In summary, PA levels are 
relatively low in the U.S. and increased PA levels have been associated with decreased 
risk for and development of many chronic diseases. 
Sedentary Behavior 
Demographics of Sedentary Behavior 
Sedentary time can be considered an independent risk factor for development of 
chronic diseases.
59
 Sedentary behavior has been defined as any waking behavior 
characterized by an energy expenditure ≤ 1.5 METs while in a sitting or reclining 
posture.
60
 Due to the use of postural muscles, standing may not be considered a 
sedentary behavior even though no movement is involved.
61
 The increase in “sitting 
time” may be a cause for chronic disease regardless of the amount of PA obtained. The 
Nurses’ Health Study showed an association between TV viewing and obesity and 
diabetes.
62
 Relative risk for developing obesity was almost double while risk of 
developing T2DM was 70% higher in those who watched 40+ hours of TV/week 
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compared to those who watched one or less hour/week.
62
 Sedentary behavior has also 
been linked to many other conditions related to T2DM and other chronic diseases.
24
 
Recommendations for Sedentary Behavior 
The recommendations for limiting sedentary behaviors do not have the same 
strength as the PA recommendations due to the relative novelty of this area of research 
and the difficulty with measurement. Research studies have examined various 
interventions including a reduction in TV time,
63,64
 increasing breaks in sedentary 
time,
65
 limiting leisure time sedentary behavior,
66
 and discouraging sitting for extended 
periods of time.
32
 Sitting time, TV time, and travel time are often used to estimate 
sedentary time, however, those are only surrogate measures for sedentary and do not 
fully capture all sedentary time. Measurement of PA and sedentary time both require 
some degree of estimation due to the complexity and diversity of activities that cannot 
all accurately be measured with current methods. One recent study suggested that, “the 
next iteration of the Physical Activity and Public Health recommendations of 
ACSM/AHA will include a statement on the health benefits of reducing and breaking 
up prolonged sitting time.”
67
 Formal recommendations for reducing sedentary time do 
not yet exist. However, one review of determinants and interventions to reduce 
sedentary behavior concluded that based on previous evidence, sitting time should be 
limited to no more than two hours per day and breaks should be taken for every 30 
minute block of sedentary time (e.g., standing up and moving around).
26
 
Sedentary Behavior and Type II Diabetes 
The mechanisms by which sedentary behavior contributes to T2DM risk have 
been studied and are beginning to be understood. One area being studied is the effect of 
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sedentary time on lipoprotein lipase (LPL), which is a protein important in controlling 
plasma triglyceride catabolism, HDL cholesterol, and other metabolic risk factors that 
are closely associated with T2DM.
59,68
 LPL is the first protein that interacts with and 
regulates lipoproteins at the cellular level and could possibly regulate other metabolic 
activities.
68
 It appears that LPL activity is acutely sensitive to muscle contraction and 
therefore long periods of sedentary time cause a prolonged decrease in LPL activity, 
especially in the red oxidative muscles.
69
 It also appears that there is a local process 
involved with LPL activity in inactive muscles which can be reversed through 
engagement in standing or light PA.
69
  Altered triglyceride metabolism has strong 
evidence showing its relationship to disease.
70,71
 Overexpression of LPL has been 




Interventions to Reduce Sedentary Behavior 
Longitudinal and intervention studies have been reviewed to describe effective 
techniques to decrease sedentary time in adults.
26,74
 Using accelerometers to measure 
sedentary time, Gardiner et al.
27
 used constructs from the Social Cognitive Theory to 
interrupt sedentary time in older adults. They used goal setting techniques, benefits and 
barriers, rewards, and identified enjoyable non-sedentary activities to increase self-
efficacy, outcome expectancies, reinforcement, and enjoyment. The goal of the 
intervention was to understand how to effectively interrupt long periods of sedentary 
time. The two-week intervention was successful at decreasing sedentary time by 3.2% 
(p < 0.001) and increasing the number of breaks in sedentary time throughout the day 
by four (p = 0.003). Another study by De Greef et al.
28
 used a face-to-face interview 
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session, pedometers, and telephone follow-ups to encourage T2DM patients to take 
10,000 steps/day and decrease sedentary time. Follow-up measures were taken at 24 
weeks and one year. The intervention group had increased steps/day by 2744 at 24 
weeks and maintained an increase of 1872 steps at one year. Additionally, the 
intervention group decreased sedentary behavior (measured by accelerometer) by 23 
min/day after 24 weeks (p < 0.05) and maintained a decrease of 12 min/day at one year 
(p < 0.001).    
Measurement Tools 
Appropriately measuring PA allows for an accurate understanding of which 
intervention techniques are effective and can therefore potentially affect health. 
Physical activity can be measured directly through direct observation, accelerometers, 
pedometers, doubly-labeled water, indirect or direct calorimetry, heart rate monitors, 
global positioning systems, or indirectly through diaries or logs, questionnaires, 
surveys, and recall interviews.
75
 Physical activity in walking programs has been 







 and self-report surveys.
19,20
 Direct observation is an accurate method of 
measuring PA because a trained observer can record every movement that another 
person makes and describe exactly the type, duration, and intensity of all activities 
performed by another person. It is, however, impractical to directly observe people in 
their daily lives for any extended period of time, so other direct methods have been 
created to measure PA. 
  Accelerometers have previously been cited in a systematic review as the most 




 They accurately measure all accelerations of the center of mass of the body 
and unlike other measurement tools, accelerometer data produces information on 
acceleration which can also be processed to obtain speed and distance information.
77
 
Accelerometers produce high quality PA data, but they are expensive and the data 




Pedometers are an inexpensive, easy to manage way to directly measure PA by 
obtaining the number of steps a person takes over a certain time period.
79
 Pedometers 
have been highly correlated with accelerometers (r = .86)
80
 and have also been 
correlated with increased PA and improved health.
81
 They have been used as 
motivational tools to increase PA as a tracking device, a feedback tool, and an 
environmental cue with minimal contact from supervisors.
82
 The Yamax SW200 
pedometer has been frequently used in walking studies,
16,18,19,21
 and has been used as a 
criterion with which to compare other pedometers.
83
 The Yamax SW model gave mean 
step counts that were within 1% of actual steps at different walking speeds and was the 
only one out of 10 models that did not differ significantly from actual steps at five 
different walking speeds.
84
 It has also been shown to be reliable in normal weight, 
overweight, and moderately obese populations.
85
      
Self-report measures have been evaluated
86
 as the most widely used and 
convenient form of PA measurement, yet have many limitations due to indirect 
measurement.
87
 Self-report measures may produce bias by influencing respondents to 
provide answers that are socially desirable.
88
  Recalling information is a complex 
cognitive task
89
 and respondents and researchers must have the same understanding of 
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the terminology of concepts being measured.
86
 Activity logs and diaries are limited by 
participant response rates and how they follow the directions.
86
 Surveys, however, are 
easy to use and can be administered on a large scale. The International Physical Activity 
Questionnaire (IPAQ) is a widely used self-report measure that has been validated 
across many countries and is able to be used to compare population health across 
countries.
90
 It assesses PA over the previous seven days and comes in a short and long 
form which breaks PA down into components of different intensities. A combination of 
indirect and direct measures will provide the most complete assessment of PA. 
Valid and reliable measurement of sedentary behavior utilizes similar methods 
to PA. The definition of sedentary behavior includes components of body position and 
metabolic rate and both components are not usually measured in each research study 
reporting sedentary behavior.
91
 Understanding the mechanism by which sedentary 
behavior contributes to disease risk will help determine which measurement technique 
to use.
91
 Currently, direct observation has been established as a criterion for PA and 
sedentary behavior measurement.
92
   
Since direct observation is not practical, other measures will be used to 
determine the amount of sedentary behavior. As described above, accelerometers have 
been used to classify PA. Sedentary behavior is defined as any activity contributing less 
than 100 counts per minute and therefore if body position is not taken into account 
accelerometers may provide a fairly accurate measure of sedentary time.
93
 Self-report 
measures may also be used for larger populations to get an estimate of sedentary time 
by using surrogates such as TV time or time to travel.
26
 A combination of these 
measures will allow for a more complete understanding of sedentary behavior. 
23 
Walking Programs 
Several significant studies are described below which include characteristics of 
effective walking programs similar to the current study, but not necessarily with T2DM 
patients.  
General Walking Programs 
The first study reviewed on this topic was conducted by Moreau et al.
94
 in 2001 
with 24 postmenopausal women (54 ± 1 yr.) who were diagnosed with borderline or 
stage one hypertension. Fifteen women were randomized to the intervention group and 
nine to the non-exercise control group. All subjects were given a Yamax SW200 
pedometer to wear for one to two weeks before the study in order to measure pre-
intervention activity levels. During the 24 week walking program, women in the 
exercise group were told to increase their total steps enough to add 1.4 km/day to their 
total daily walking. One half a km was added each week until they were walking three 
km/day above their baseline value. They used daily log sheets to track their step values 
and were allowed to accumulate steps in whatever pattern best fit their lifestyles. The 
control group was asked to maintain their current lifestyle habits and they measured 
their steps one week each month to document activity levels. Outcome measurements 
were taken at baseline, 12 weeks, and 24 weeks and included resting blood pressure, 
fasting glucose and insulin, body composition (using a BOD POD), and three-day 
dietary food records. At baseline, the exercise group walked significantly less than the 
control group (5400 ± 500 steps/day, 7200 ± 700 steps/day, respectively, p < 0.05). 
However, women in the walking group increased their walking by 4300 steps to 9700 ± 
400 which was different from baseline and the control (p < 0.05). Women in the control 
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group did not change their walking over the 24 weeks. The exercise group reduced body 
mass by 0.9 ± 0.3 kg after 12 weeks (p < 0.05) and an additional 0.3 kg after 24 weeks 
of walking (p < 0.005). After 12 weeks, fasting insulin increased in the control group by 
23% and remained elevated at 24 weeks (p < 0.05), but did not change in the exercise 
group. Body composition, dietary intake, resting heart rate, fasting glucose, and HOMA 
did not change in either group. Resting systolic BP was reduced in the exercise group at 
12 weeks by six mm Hg (p < 0.005) and was further reduced by five mm Hg after 24 
weeks (p < 0.005). Diastolic BP did not change and neither systolic nor diastolic 
changed in the control group. Detailed intervention methods were not described nor 
were discussions included that hypothesized what made the program successful at 
increasing PA.     
Another study was performed by Miyatake et al.
10
 in 2002 with 31 Japanese 
male subjects with a BMI ≥ 25 and between the ages of 32 and 59. The subjects were 
instructed to record their daily steps using a pedometer (Seiko WZ100A). They 
increased their steps by 1000 above their baseline level and maintained their current 
dietary behaviors. Body composition, submaximal aerobic capacity, muscle strength, 
gait speed, flexibility, BP, and fasting cholesterol, HDL, triglycerides, insulin, and 
glucose were measured before and after the one year intervention. Although little 
information was given on what was done to increase PA, average daily steps were 
increased during the study from 7012.5 ± 3076.7 to 8839.7 ± 4342.2 (p < 0.05). HOMA 
index (a calculation of insulin resistance), fasting glucose, and insulin were significantly 
decreased following the study (p < 0.01). Body composition measures improved along 
with aerobic exercise level, leg strength, and weight bearing index (p < 0.01). In 
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addition, SBP and DBP improved (p < 0.05) along with triglycerides and HDL 
cholesterol (p < 0.05). This study protocol appeared to be very effective at improving 
many health characteristics by increasing steps by less than 2000 per day over the 
course of one year. However, it is not clear what intervention techniques facilitated the 
high compliance rate and/or what influenced the participants to maintain increased 
activity for the entire one year study.  
The next study was performed by Swartz et al.
9
 in 2003 with 18 sedentary 
women between 40 and 65 who had a family history of T2DM and an average BMI of 
35 (± 5.1 kg/m
2
). The intervention included a four-week control period where 
participants did not change PA levels followed by an eight-week walking period where 
participants increased walking to meet the recommended 10,000 steps/day. Pedometers 
(Yamax SW200) were used to track steps on a step log and diet was kept constant 
throughout the study. Measurements were taken at the same time during the day at 
baseline, four weeks, and 12 weeks and included resting HR, body composition (BOD 
POD), waist and hip girth, oral glucose tolerance, and fasting plasma glucose and 
insulin. Participants increased their daily steps from 4972 ± 419 to 9213 ± 362 during 
the intervention. Two-hour post-load glucose decreased by 11% (p < 0.001), area under 
the curve of glucose decreased (p = 0.025), and systolic BP and diastolic BP decreased 
(p < 0.001, p = 0.002, respectively). All other variables did not change significantly. 
Little information was given on how the program was administered and what methods 
were used to increase and maintain increased walking in the participants.    
  Chan et al.
95
 performed a walking program for 92 women and 14 men at five 
worksites in Canada in 2004. All of their jobs were sedentary in nature and 55% of the 
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employees engaged in strenuous PA (producing sweat and elevated heart rate) less than 
three days/week. The average age of the participants was 43 ± 9 years with a BMI of 
29.5 ± 6.2 kg/m
2
 and average daily steps of 6981 ± 3140 for women and 7661 ± 2474 
for men. The walking program was based off of the First Steps Program and was 
organized into a four-week adoption phase followed by an 8-week adherence phase. 
Facilitators were hired to administer the program at each workplace and held 30-60 
minute learning sessions for the adoption phase to teach strategies for goal setting, 
benefits to PA, and strategies for overcoming relapse. Steps were recorded using a 
pedometer (Yamax SW200). During the adherence phase, subjects received minimal 
contact with the researchers and monitored their own progress and goals. 
Anthropometric measures, resting HR, BP, and steps/day were measured before and 
after the program. Steps/day increased from 7029 ± 3100 at baseline to 10480 ± 3224 
where they hit a plateau about four weeks into the intervention. Body weight, BMI, 
waist girth, and resting HR significantly decreased following the intervention (p < 
0.001), however, there were no significant interactions between each of the predictors. 
This study demonstrated that it takes some time for sedentary people to adapt to a new 
program and that after 12 weeks there can be significant anthropometric and 
cardiovascular changes. Instructional sessions at the start of a walking program appear 
to be effective at helping people maintain higher activity levels.    
Hultquist et al.
96
 recruited 73 sedentary women between 33 and 55 to participate 
in a walking study comparing a recommendation to walk 10,000 steps versus a 
recommendation to walk for 30 minutes. Participants’ PA was measured using the New 
Lifestyles NL-2000 pedometer over the course of 14 consecutive days. These 
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participants walked an average of 5760 ± 1143 steps/day at baseline and had an average 
BMI of 29.6 ± 6.1. The 4-week intervention included a group that wore a sealed 
pedometer; they were told to take a brisk 30 minute walk on most or all days of the 
week. They kept activity logs to track PA, but were not aware of the number of 
steps/day. The second intervention group was instructed to walk 10,000 steps/day which 
was recorded using a sealed pedometer and a second pedometer that could be reset each 
day as they tried to obtain the 10,000 steps/day. All of the subjects returned to the lab to 
have their sealed pedometer data and activity logs collected. Over the four weeks the 
group assigned to walk for 30 minutes accumulated an average of 8270 ± 354 steps/day 
while the group assigned to walk 10,000 steps/day averaged 10159 ± 292 steps/day. 
There was no significant difference in average daily steps in the 30 minute walking 
group while the group assigned to take 10,000 steps/day significantly increased steps 
even if the goal of 10,000 steps was not achieved (p < 0.05). Blood pressure 
significantly changed over time for both groups (p < 0.05). It appears that a 
recommendation of “30 minutes” will result in reaching the recommended amount of 
daily steps when followed, but this recommendation is not followed as often as is with 
the recommendation of “10,000 steps”. A specific recommendation of 10,000 steps 
appears to effectively increase PA on more days/week in the short term compared to the 
30 minutes/day recommendation. No other motivational techniques were mentioned as 
a means to increase activity except for goals setting and tracking behavior.  
In 2005 Wilson et al.
97
 implemented an eight-week walking program with 22 
breast cancer survivors who had completed treatment for at least three months prior to 
starting the study. The participants were African American and under 70 years old. The 
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intervention was based on the Health Belief Model and included eight 75-minute 
weekly sessions designed to educate participants on the perceived seriousness and 
susceptibility of disease risk related to physical inactivity. They tracked walking using a 
scheduler/tracker and a pedometer. Measurements were taken before the intervention, 
following the eight-week intervention, and three months after the conclusion of the 
intervention. Physical activity was measured with the pedometer, and BMI, other 
anthropometric measures, blood pressure, and attitudes were also measured. Seventy 
percent of the participants attended at least seven of the weekly meetings and about 
25% reported lost or broken pedometers which were replaced. Average steps increased 
from 4791 to 8297 steps/day from pre- to post-test which was a significant increase (p < 
0.001). Hip circumference (p < 0.009), forearm circumference (p < .001), systolic BP (p 
< 0.002), diastolic BP (p < 0.001), and attitude toward exercise also significantly 
changed following the intervention. Attitude toward exercise improved by the end of 
the intervention, but at the three month follow-up that attitude had declined again 
despite no change in steps/day. This study shows the effectiveness of an eight-week 
walking program at increasing activity which potentially affects health outcomes, which 
may not persist long-term after the study because attitudes became more negative as 
soon as three months after the intervention. 
An internet-mediated walking intervention was administered by Richardson et 
al. 
98
 where 324 individuals were randomized into two intervention groups to increase 
PA. The average age was 52 ± 11.4; two-thirds of the individuals were female. All 
participants were required to have at least one of the following criteria: BMI ≥ 25, 
T2DM, or coronary artery disease and all were required to be getting less than 150 
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minutes of moderate PA each week. Subjects were randomized into two groups where 
all received individually tailored, web-based motivational messages, weekly goals, and 
graphs to track their progress. While one group was allowed to read and post online 
messages, the other group was not. The main outcomes measured were participant 
attrition and daily step counts measured by Omron HJ-720-ITC pedometers. Social 
cognitive theory and social influence theory were used as theoretical underpinnings for 
the interventions. Both intervention groups increased steps by 1888 ± 2400 steps (about 
1 mile) with no difference in increase between groups. The online community group 
uploaded valid pedometer data on more days than the no online group (79% vs. 66%, 
respectively, p = 0.001). Online community participants remained engaged in the 
program longer than those not engaged in the online community (p = 0.02) and those 
with lower baseline social support posted more messages to the online community (p < 
0.001) and viewed more posts (p < 0.001) than participants with higher social support at 
baseline. This study shows that adding an online feature to an internet-mediated 
walking program may not increase steps/day, but can help retain more participants and 
support especially those who do not currently have adequate social support.   
Walking/Diet Programs in Type II Diabetes and Impaired Glucose Tolerance in Adults 
Yamanouchi et al.
43
 performed a walking and diet intervention on obese patients 
who had been diagnosed with T2DM within one year of the start of the study. 
Participants were sedentary and had not participated in regular exercise. Ten were 
assigned to the diet only group and fourteen were assigned to a diet plus exercise group 
with both groups matched for age, sex and BMI. All participants were hospitalized and 
received a supervised diet for six to eight weeks including: 1,000-1,600 kcal/day (54-
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58% carbohydrate, 17-20% protein, and 25-26% fat). The diet plus exercise group was 
instructed to walk 10,000 steps/day (OMRON HJ-7 pedometer). Both groups 
significantly decreased in body weight (p < 0.01) but the decrease was greater in the 
diet plus exercise group. Blood glucose concentrations in both groups were similar at 
pre-test and both groups slightly improved (p < 0.05) at post-test along with decreased 
insulin levels in the diet plus exercise group only (p < 0.05). Insulin sensitivity also 
improved in the diet plus exercise group (p = 0.0005) with a significant correlation with 
steps/day (r = 0.7257, p < 0.005) in the diet plus exercise group. The addition of 
walking to a strict medical diet improved insulin sensitivity and reduced weight in six to 
eight weeks. The recommendation of 10,000 steps appeared to be more effective 
because the diet plus walking group reached 19,200 ± 2,100 steps/day while the diet 
only group walked 4,500 ± 290 steps/day. 
In a study by Walker et al.,
99
 11 postmenopausal women with T2DM and 20 
normoglycemic women participated in a 12 week walking program. The women 
followed their normal diet and were instructed to walk for at least one hour on at least 
five days/week. Participants were told to write start and stop times for their walk 
sessions and to walk at their own paces. Fitness was measured using heart rate and time 
to complete a 1.6 kilometer walk to estimate maximal aerobic capacity. Following the 
12 week intervention, both groups exhibited an improvement in maximal oxygen 
consumption (p < 0.005). The diabetic women decreased in BMI and fat content in the 
upper body and waist region decreased (p < 0.05) along with fasting blood glucose 
levels (p < 0.05), HbA1c (p < 0.05), total cholesterol (p < 0.005), and LDL cholesterol 
(p < 0.05). HDL cholesterol and sex hormones did not change. The normoclycemic 
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women failed to lose body fat following the intervention, but they did decrease HbA1c, 
total cholesterol, LDL cholesterol, and sex hormones (p < 0.05). However, the 
normoglycemic women walked more than the women with T2DM (4.8 ± 2.3 hr/week 
and 4.1 ± 1.6 hr/week, respectively) despite greater measured improvements in the 
T2DM women. Both groups reported similar energy intakes, but women with T2DM 
may have had to expend more energy for the same workload as the normoglycemic 
women and therefore were able to change their respective body composition. Walking 
for an hour a day appears to be beneficial in many ways to women with and without 
T2DM.       
An internet based PA program was performed by McKay et al.
100
 with T2DM 
patients. All participants were at least 40 years old and did not meet the ACSM PA 
guidelines of 30 minutes of moderate intensity PA on five days/week. Seventy eight 
participants (53% female) were randomized into the study with 40 in an information-
only group and 38 in an internet intervention group. Those in the information only 
group had access to a website with diabetes articles and could track their blood glucose 
for the eight week study. Participants in the intervention group received a personalized 
eight week PA program. Intervention participants identified benefits and barriers to PA, 
preferred activities, and goals, then received tips and information on how to achieve 
their goals. Participants had online access to personal coaches who provided 
individualized support and access to health professionals to give advice on how to 
answer questions. A social support conference area was also provided on the 
intervention website for members of the intervention group to post comments and 
interact with other members of the intervention. There was a moderate improvement in 
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PA in both groups and a wide variety in the usage profile of all participants. 
Intervention participants found that the personal coach was helpful (88%) while only a 
few found the peer support aspect to be helpful (23%). Participants who used the 
website the most derived the most benefit in increasing PA.      
The Diabetes Prevention Program Research Group performed a large scale 
(3234 participants) intervention for people with risk factors for T2DM.
101
 Participants 
had a BMI of 24 or higher, high fasting blood glucose levels (95-125 mg/dl) and blood 
glucose levels of 140-199mg/dl following an oral glucose tolerance test. They could not 
have been diagnosed with diabetes prior to entry into the study. A four-step screening 
process was used to recruit with an emphasis on racial/ethnic minorities. Participants 
were randomly assigned to one of three interventions: standard lifestyle 
recommendations plus metformin, standard lifestyle recommendations plus a placebo, 
and an intensive lifestyle intervention. Physical activity and dietary recommendations 
for the metformin and placebo groups followed the Food Guide Pyramid guidelines to 
reduce their weight and increase PA. Members in the intensive lifestyle intervention 
were instructed to reach and maintain a seven percent body weight reduction through a 
low-calorie, low-fat diet and at least 150 minutes of brisk walking every week. A 
curriculum was taught on a one-on-one basis for 24 weeks to each lifestyle intervention 
participant with individualized counseling on how to achieve their goals and reinforce 
behavior changes. The average follow-up was 2.8 years and incidence of T2DM was 
11.0, 7.8, and 4.8 cases per 100 person-years in the placebo, metformin, and lifestyle 
groups, respectively. The weight loss goal of 7% of body weight was reached by 50% 
of the lifestyle intervention group and 74% of the intervention participants met the goal 
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of 150 minutes of PA each week. The lifestyle intervention decreased T2DM incidence 




 recruited 75 patients with T2DM to participate in a 
nutrition and exercise program for a 12-week randomized controlled trial. Those in the 
intervention group received 11 weekly nutrition classes (90 minutes each) and were 
encouraged to bring family members. They also participated in 60 minute group 
walking sessions three times per week for 12 weeks. Sixty-one of the initial 75 subjects 
completed the study. Thirty-three subjects were assigned to the intervention group and 
20 of them attended more than 70% of the nutrition classes and nine subjects attended 
the walking groups at least 60 minutes per week. At the end of the 12 week period, the 
intervention group had lost 1.0 ± 2.2 kg of weight, decreased fasting blood glucose 
levels by 19 ± 55 mg/dl, and lowered HbA1c by 1.8 ± 2.3%. The control group gained 
0.4 ± 2.3 kg, increased fasting blood sugar by 16 ± 78 mg/dl, and decreased HbA1c by 
0.4 ± 2.3%. Weight, fasting glucose levels, and HbA1c levels were all significantly 
different between groups (p < 0.05).  
In 2004, Mshunqane et al.
11
 randomly assigned 30 T2DM patients to a medical 
exercise intervention group or an at-home exercise intervention group. Exercise time 
was used to determine program progression. Participants in the at- home exercise group 
were told to record walk time in an exercise diary and to start off with at least 10 
minutes per day and increase to 30 minutes per day on alternate days. Those in the 
medical exercise group were supervised by medical staff at a hospital and performed 
either the same protocol as the at-home walking group or cycled at an intensity of at 
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least 70% maximal heart rate for six minutes initially and worked up to 30 minutes. 
Twenty-four participants completed the study and mean fasting glucose levels, exercise 
capacity, body weight, body fat percentage (skinfolds) were all improved following the 
intervention (with no significant differences between groups, p < 0.05). This study 
suggests that there may be no additional advantage to a medically supervised exercise 
program compared to a home-based program. 
Van Rooijen et al.
102
 implemented a home-based walking program and 
compared the effects to a relaxation program in South Africa. One hundred fifty-eight 
women were randomized into the exercise or relaxation group. The exercise group was 
encouraged to walk in groups with other women and to increase walking session length 
from 10-45 minutes over the 12 week training period. Participants were instructed to 
walk twice per day, starting with five minutes per session and increasing by 10 minutes 
per session every two weeks until 45 minutes per session was reached. Duration of PA 
was recorded on an activity log. A 45 minute exercise session was held at the hospital 
once every two weeks to educate subjects about how to exercise and provide an 
environment to exercise with trained instructors. The relaxation group was required to 
attend an education session at the hospital once every two weeks and was told to 
perform progressive relaxation exercises in their homes. Both the exercise group and 
relaxation group significantly decreased HbA1c levels (-.39% and -.97%, respectively), 
but the group differences were not significant (p = 0.052). The exercise group did walk 
significantly farther than the relaxation group (46.76 m and 22.7 m, respectively, p < 
0.01). The increase in PA did not improve blood glucose control with this intervention 




 randomized 92 T2DM patients into a 12-month brisk walking 
program or a medical fitness program. Those in the brisk walking group were 
supervised by a certified trainer and a physical therapist for three, 60-minute sessions 
per week for the first three months. Exercise sessions consisted of an aerobic 
component which included interval type walking at 5-6 km/hr with the intensity 
gradually increasing to about 75 ± 5% of maximal heart rate. The resistance exercises 
consisted of floor exercises with body weight and resistance exercises using elastic 
bands. The medical fitness program consisted of three sessions per week using a home 
trainer, elliptical trainer, or a rowing ergometer at an average intensity of 73 ± 2% of 
maximal heart rate and was tailored to individual exercise capacity. The resistance 
training included eight exercises targeting upper and lower body muscle groups and was 
progressively increased in intensity over a six month period from three times, 30 
minutes per week toward a goal of 180-225 minutes per week. At six months, 22 (45%) 
brisk walking participants and 13 (30%) of the medical fitness program participants had 
dropped out of the study. At 12 months 18 (37%) brisk walking and 19 (44%) medical 
fitness participants still actively participated in the program. Motivational issues 
accounted for 25% of the dropout with a variety of injuries and co-morbidities 
accounting for the remaining drop outs. No significant changes occurred over time or 
between groups for fasting blood glucose, HbA1c, HOMA, or BMI. Neither program 
appeared to be very successful with small changes and a high attrition rate.    
Furber et al.
104
 conducted a two-week walking intervention with 226 T2DM 
patients or people with imparied glucose tolerance who participated in education 
courses which were designated as intervention and conrol without participants knowing 
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beforehand. Both groups attended the educational sessions which covered diabetes 
physiology, diabetes care, and PA. The intervention group also received instruction on 
how to use a pedometer and participants were asked to record their daily steps for two 
weeks following the education sessions. They were also encouraged to set their own PA 
goals such as reaching a certain step number or amount of time spent in PA. Two 
hundred and ten participants completed the two-week follow up and 184 completed the 
20-week follow up. Self-reported minutes walked were higher in the intervention group 
compared to the control (223 min. and 164 min., respectively, p = 0.01). Participants in 
the intervention group also got more moderate intensity PA (63.5%) compared to the 
control (41.8%, p = 0.02). This intervention was effective in improving PA using 
education and a pedometer in the short term, but did not produce changes that could 
significantly affect disease status. 
A one year hospital-based intervention was conducted by Hordern et al.
105
 with 
diagnosed T2DM patients to assess the effectiveness of a supervised exercise program 
compared to standard care. The exercise intervention consisted of general dietary 
guidelines and a two-stage exercise program. The exercise program began with a four-
week supervised gym-based program, followed by a home-based training program 
aimed at attaining at least 150 minutes of PA per week. The program consisted of 
aerobic and resistance training and supervisors provided telephone counseling once a 
week for the first three months of home-based exercise, once every other week for the 
second three months, and once a month for the rest of the program. The intervention 
group participated in more vigorous PA compared to the controls throughout the 
intervention (p < 0.01), but with no difference between groups in time spent walking. 
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The intervention group improved in waist circumference, fat mass, fasting glucose 
levels, HbA1c levels, and aerobic capacity (p < 0.05).  
Cheong et al.
40
 designed a 16 week walking versus walking plus diet 
intervention for T2DM patients based on Social Cognitive Theory constructs. Twenty-
two participants were randomized to each group and all participants attended four 60-90 
minute group meetings for the first four weeks and received two motivational postcards 
at weeks six and ten to encourage adherence. All participants recorded daily steps and 
set goals to gradually increase step values. Participants in the walking plus diet 
intervention received counseling on how to eat a low glycemic diet. Both groups 
increased their total daily steps at week 16 by about 3,000 steps compared to baseline (p 
< 0.01). Differences between groups did not exist for any variables, indicating that the 
addition of a low glycemic index component to a walking program did not add any 
additional benefit to a T2DM intervention program. However the program did induce a 
decrease in waist girth, hip girth, but no difference in HbA1c over time.    
Shenoy et al.
12
 recruited 40 T2DM patients in India to participate in an eight-
week walking intervention using a pedometer and heart rate monitor. Participants were 
randomly assigned to the walking group or a standard care control group. Those in the 
walking group were instructed to use a pedometer and heart rate monitor to implement a 
30 minute exercise session five days per week at a heart rate 50-70% of maximum. The 
goal was to go from approximately 3,000 to 4,000 steps per half hour exercise session 
and reach 70% maximum heart rate by the end of the study. Intervention participants 
kept a daily diary of PA and were told not to change their current diet. Following the 
eight-week intervention, the intervention group exhibited a significant decrease in 
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HbA1c from 7.25 ± 1% to 6.5 ± 0.87% (p = 0.0001) which was significantly different 
than the control (p < 0.01) which did not change. Fasting blood glucose values were 
different between groups at initial testing, and both groups significantly decreased blood 
glucose at the end of the intervention period (p < 0.01). Body Mass Index decreased in 
the intervention group (p < 0.01) and significantly increased in the control group (p < 
0.01). This intervention appeared to be effective at improving health parameters in 
patients with T2DM.  
Morton et al.
106
 performed a similar study to the previous intervention conducted 
by Shenoy et al. and used heart rate to prescribe a seven-week walking program to 
improve health parameters in T2DM patients. Morton et al. randomly assigned 27 
patients with T2DM to a seven-week supervised walking program which met four times 
per week and was monitored by heart rate monitors. There were no changes in HbA1c 
levels due to training, but there were improvements in sub-maximal cardiorespiratory 
responses which are beneficial to patients with T2DM. 
Van Rooijen et al.
42
 randomized 51 participants with T2DM into intervention 
and control groups to implement a walking and nutrition intervention in South Africa. 
Both groups received usual care while the intervention group also attended four weekly 
group sessions where they were given knowledge and skills to eat healthier and control 
blood sugar levels. They also received a pedometer to wear and walk at least 10,000 
steps per day on at least five days per week. At 16 weeks the pedometers were returned 
and the intervention participants were told to continue their walking and diet program. 
Follow-up occurred at 16 weeks and one year. Hemoglobin A1c levels of the 
intervention group were significantly lower after 16 weeks (p < 0.05) compared to the 
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control, but were not different at one year. Diabetes knowledge was higher in the 
intervention group at 16 weeks and at one year (p < 0.01).  
A final study by Negri et al.
107
 randomized 59 T2DM patients in a one to two 
ratio to a control group or walking intervention. The walking intervention consisted of 
supervised walking sessions held by a personal trainer three times per week. The 
walking was at a low intensity and progressed to a moderate intensity through the four-
month walking program. Intervention participants also participated in one individual 
and one group counseling session. After four months, the intervention group had higher 
exercise capacity, but there were no differences in glycemic or metabolic variables. 
When the intervention group was separated into only those who attended at least 50% of 
the exercise sessions, those that complied with the exercise program did significantly 
differ compared to the control group in HbA1c (p = 0.01) and fasting glucose levels (p 
= 0.05). The researchers concluded that participants must be compliant with the exercise 
program in order to obtain physiological benefits.   
Pedometer-Based Walking Programs in Free-Living Adults with Type II Diabetes 
In this section, several studies are described from a systematic literature review 
performed using MEDLINE, CINAHL, SPORTDiscus, ERIC, and Academic Search 
Premier.
15
 Combinations of the following keywords were used: walk, walking, 
intervention, and type 2 diabetes. The primary focus was on interventions designed to 
increase PA in the form of walking using a pedometer to motivate, measure, track, and 
improve health outcome variables. Articles from 1995 to 2011 were included in the 
search. 
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The first study was conducted by Tudor-Locke et al.
16
 in Ontario, Canada with 
60 people with previously diagnosed T2DM (minimum 3 months post-diagnosis). 
Participants were required to be inactive (< 8800 steps/day) and not taking insulin. 
Eligible participants were randomized into intervention and control groups with 47 
completing the 16-week intervention. The intervention group attended a weekly group 
meeting for the first four weeks where they were taught principles of self-monitoring 
and problem-solving. They were also given a pedometer and a program manual which 
contained additional information and activities on goal-setting and problem-solving. 
Intervention participants were asked to use their pedometers and calendars for goal-
setting and self-monitoring during the remaining 12 weeks of the program. Participants 
in the control group received no intervention. At 16 weeks, the pedometers and 
calendars were collected from the intervention group to find that they had significantly 
increased steps/day compared to the pretest and control group. However, at the 24 week 
follow up the steps/day in the intervention group were no longer significantly different 
than the control group. Waist girth decreased over time (p = 0.025), but not between 
groups (p = 0.128). Correlations of the baseline data for those taking oral hypoglycemic 
medications revealed an inverse relationship between steps/day and fasting blood 
glucose (p = 0.0001), glucose at 120 min. postglucose load (p = 0.02), and HbA1c (p = 
0.003) indicating that those who were more active at baseline were at lower risk of 
disease progression. This study showed that through group meetings, a walking 





The second study by Engel et al.
22
 focused on using health coaching and 
pedometers to increase PA in T2DM patients (mean = 8 years post-diagnosis) in 
Australia. Fifty-four inactive (< 150 min. PA/week) people were randomized to 
participate in the study and all received health coaching focused on education, goal 
setting, and supportive/motivational strategies aimed at increasing walking time. The 
average BMI was 32kg/m
2
 with an average participant age of 62 years. Each group 
received six visits: 1- baseline measures (BP, HbA1c, anthropometric and fitness 
measures), 2- physical activity strategies explained and health logs given, 3 and 4- 
emotional/social support, 5 and 6- baseline assessments taken again. The coaching-only 
group received an activity log and was counseled how to set goals and record activity 
time each week. The coaching + pedometer group received the same materials as the 
coaching-only group with the addition of a pedometer which they used to record 
steps/day. Assessments were taken at baseline, three months, and six months. The 
coaching-only group spent significantly more time walking than the coaching + 
pedometer group at both three and six month follow ups (p = 0.02). When analysis of 
covariance was used to control for all other variables, the between group differences 
disappeared (p = 0.207). With all the subjects combined, there was a significant 
reduction in waist circumference and weight at both three and six months (p < 0.05). 
Changes in BMI occurred only at six months (p < 0.05) while cardiovascular fitness 
increased at three months and was maintained at 6 months (p < 0.001). Overall, the 
addition of a pedometer added no extra beneficial effect beyond a coaching intervention 
for these T2DM patients.
15
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The third study by Araiza et al.
108
 in New Mexico focused on improving various 
physical parameters of T2DM patients through walking 10,000 steps/day on five or 
more days/week. Participants had been diagnosed with T2DM for at least a year and all 
were taking oral hypoglycemic medications. Fifteen subjects were randomized into the 
active group and 15 into the control with an average age of 50 years. The active group 
received a pedometer and was instructed to walk 10,000 steps/day on five or more 
days/week and maintain their current diet for six weeks while the control group 
received no pedometer or intervention. The active group increased their steps 69% to 
10410 ± 4162 steps/day (p = 0.002) while the control group did not change. Resting 
energy expenditure increased in the active group (p = 0.014) along with HDL-C (p = 
0.022) while plasminogen activating inhibitor-1 decreased in the active group compared 
to the control (p = 0.03). Little information was given on how the program was actually 
implemented to understand what might have contributed to the participant’s success in 
reaching the desired number of steps/day or why there was no attrition in this study.
15
 
The fourth study was performed by Richardson et al.
109
 in Michigan to 
determine if a target goal of steps/day or a focus on walking intensity of PA bouts 
would be more effective at increasing PA among sedentary (< 150 min. PA/week) 
adults with T2DM. Thirty participants completed this randomized pilot trial in which all 
subjects used an enhanced pedometer for six weeks and received individual goals and 
motivational messages (using Health Belief Model constructs) from the study website. 
Participants in the lifestyle group focused on increasing total daily steps while those in 
the structured group focused on bout steps (bouts of walking that last for at least 10 
minutes each at an intensity of 60 steps/min). Pedometer information was uploaded onto 
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a computer and goals were automatically calculated based on performance over the 
previous seven days with a maximum goal of 10,000 steps/day. Both groups 
significantly increased average daily bout steps by 1921 ± 2729 (p = 0.0006) and total 
average daily steps 1938 ± 3298 (p = 0.0032) with no differences between groups. The 
lifestyle group had higher satisfaction with the program compared to the structured 
group (100%, 62%, respectively), reporting that they would definitely recommend the 
walking program to a friend. Structured goal participants felt like they did not get credit 
for their shorter walks if they were not able to walk for at least 10 minutes. The 
structured goal group wore the pedometers for less time each day compared to the 
lifestyle group (14.5hrs, 16.5hrs, respectively, p = 0.038). According to this study, it 
appears that a total steps/day count is more satisfying, and just as effective at increasing 
PA, as including a recommendation to get bouts of a certain time and intensity.
15
 
The fifth study was done by Bjorgaas et al.
23
 in 2008 to investigate whether the 
addition of a pedometer would increase walking and influence clinical outcomes in 
people with T2DM in Trondheim, Norway. Seventy people (mean age = 58) started the 
study and 22 dropped out due to illness, work commitments, and personal 
circumstances. All of the participants were instructed to keep a log of all their major 
physical activities and to increase their PA between each visit. Participants in the 
pedometer group were told to monitor and increase their step count each day while 
those without a pedometer were told to increase their time spent doing PA. All the 
participants were given strategies to increase walking in addition to setting reasonable 
PA targets to reach between each visit. Aerobic capacity was lower in those who 
dropped out, indicating that those who needed the intervention most were not able to 
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complete the intervention. Participants in the pedometer group did not increase steps 
from month one to month six (p = 0.65) which therefore could indicate that the 
pedometers may not have been effective at increasing PA in this population. The 
clinical variables were not significantly different between groups (all p values greater 
than .38), but combined there were decreases over time in body weight (p = 0.005), 
HbA1c (p = 0.034), fasting glucose (p = 0.033), triglycerides (p = 0.002), diastolic BP 
(p = 0.048), and increased HDL cholesterol (p < 0.001). These results indicate that a 
pedometer may not be necessary or helpful at increasing PA levels in people diagnosed 
with T2DM who receive PA counseling under the conditions of this intervention.
15
 
The sixth intervention by Johnson et al.
18
 included 41 participants in Alberta, 
Canada with a baseline walking program for 12 weeks, followed by two different 
variations to the program plus a dietary component for an additional 12 weeks. Changes 
in cardiovascular and glycemic health due to the increased PA were primary outcomes. 
Participants were T2DM patients that were not using insulin, able to walk, and were 
between 40 and 70 years old (mean age = 56.5). The participants used a pedometer and 
walk log to increase their daily steps for the first 12 weeks. Mandatory group meetings 
were held for the first four weeks which included a supervised group walk session. For 
the following eight weeks optional walk sessions were held and all subjects were asked 
to record and increase their daily steps based on their baseline measures. At 12 weeks, 
participants were randomized into either the Basic Lifestyle Program (BLP) or the 
Enhanced Lifestyle Program (ELP). During weeks 13-16 all participants were asked to 
attend a weekly meeting with their assigned program including a supervised walk 
session. During weeks 17-20 participants attended two weekly booster sessions and 
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during weeks 21-24 they attended only one booster session per week. The BLP 
continued with the same walking program as the first 12 weeks and continued to 
increase daily steps while adding a nutrition component to decrease high glycemic 
index (GI) foods. The ELP group continued the same number of steps that they walked 
during weeks 10-12, but were told to increase their walking speed by 10% during a 30 
min walk session performed on at least three days of the week in at least 10 minute 
intervals. The ELP group also received the same dietary instructions to decrease intake 
of high GI foods and exchange them for low GI foods. The change score for steps/day 
was significant in all subjects over the first 12 weeks with an increase of 1562 steps (p = 
0.02). Body weight, BMI, and systolic and diastolic blood pressures also decreased 
significantly over the 12 weeks of walking (p < 0.01). Following the 24
th
 week, no 
group differences existed on all measures except for resting pulse rate which was lower 
in the ELP compared to the BLP (p = 0.03). These programs show that walking seems 
to be beneficial to cardiovascular health but goals to increase walking intensity do not 
seem to be more effective than simply increasing number of steps/day.
15
 
The seventh study was described by Deborah Vincent
 
using Mexican Americans 
diagnosed with T2DM (mean = 7.9 years post-diagnosis).
17
 Following randomization, 
the intervention group attended weekly group meetings for the eight week duration of 
the study. The meetings included education, demonstrations, and group support. The 
intervention group received pedometers and was instructed on how to use them and that 
they should record their daily steps. They were also encouraged to bring family 
members to the meetings to provide social support. Average steps/day increased from 
baseline to eight weeks in the intervention group (p = 0.03) along with a decrease in 
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weight (p = 0.03) and BMI (p = 0.03) over time. There was a slight increase in weight 
and BMI in the control group, though not significant. This study shows that including a 
pedometer in a culturally tailored walking program for Mexican Americans could be 
beneficial at increasing activity levels in the short term.
15
 
The next study by Diedrich et al.
19
 included 53 T2DM patients (mean age = 54.2 
years) in the U.S. who were enrolled in a Diabetes Self-Management Education 
Program (DSMEP). Individuals were randomly assigned to the intervention or control 
group and each group participated in the DSMEP program which included a two-hour 
assessment and eight hours of educational group meetings. In addition to the DSMEP 
program, the intervention subjects received a pedometer, a copy of the book “Manpo-
ki” (“Manpo-ki” is the Japanese term for pedometer), and a concise summary handout 
with important points from the book. They were instructed to read the book and record 
their steps using the pedometer and logbook which they were given. Those who 
completed the 12 week study received a $50 gift card. The two groups were equal at 
pretesting and 62% of the participants completed the study. The number of those who 
reported regular PA increased in both groups and steps increased in the pedometer 
group (p = 0.01). The intervention group decreased HbA1c levels (p = 0.002), weight (p 
= 0.011), and body fat (p = 0.037) following the intervention, however these variables 
were not different between groups. The control group also showed a significant 
decrease in HbA1c (p = 0.005) and weight (p < 0.001). Diastolic BP was the only 
variable that was different between groups at post-test with a favorable decrease in the 
intervention group compared to the control (p = 0.024). This intervention seems to show 
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that this DSMEP program was just as effective with or without a pedometer on the 
variables measured in this study.
15
   
De Greef et al.
21
 performed a 24-week pedometer-based walking intervention in 
Belgium with 92 T2DM patients who had been diagnosed for at least six months and 
were being pharmaceutically treated, but had no physical limitations. The participants 
were 69% male with a mean age of 62 and a mean BMI of 30 kg/m
2
. The intervention 
was based off of cognitive-behavioral therapy, the Diabetes Prevention Program, the 
First Step Program, and Motivational Interviewing. It began with a face-to-face session 
with a psychologist which lasted for about 30 minutes and consisted of a motivational 
interviewing component followed by the creation of an individualized lifestyle plan 
describing when, where, and how the intervention would take place. Participants 
received a phone call every two weeks for the first four weeks and then every four 
weeks for the remaining 20 weeks. The calls lasted about 20 minutes and provided 
counseling on goal-setting, self-monitoring, self-efficacy, benefits, decision balance, 
problem-solving strategies, social support, and relapse prevention. Patients were given a 
pedometer with the goal of reaching 10,000 steps/day by monitoring and recording their 
steps. The control group received usual care. Following the 24-week intervention, the 
intervention group increased their steps/day by 2744 while the control group decreased 
by 1256 (p < 0.001). Changes remained after one year in both groups with an increase 
of 1872 in the intervention group and a decrease of 1275 in the control (p < 0.001). The 
effects were confirmed by accelerometer with the intervention group increasing total 
activity in the short and intermediate term and the control group decreasing total 
activity. The IPAQ also confirmed a decrease in sedentary time in the intervention 
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group with an increase in the control group. This intervention appeared to be effective 




The final intervention also took place in Belgium by De Greef et al.
20
 with 67 
patients (mean age = 67.4 years) diagnosed with T2DM. The 12-week pedometer-based 
program compared delivery of the materials through group counseling and general 
practitioner counseling, in addition to a control group. Both intervention groups 
received a pedometer and a diary as motivational tools and to use in setting goals. 
Participants were asked to record their number of steps/day and the type and duration of 
their PA. Those assigned to group counseling participated in three 90 minute sessions 
led by a behavioral expert who used techniques based on cognitive-behavioral therapy. 
The other intervention group received three 15 minute sessions with a general 
practitioner who received training from the behavioral expert to deliver some of the 
components that were discussed in the group sessions. An overall time by group effect 
was observed (p ≤ 0.05) for daily step counts with the group counseling participants 
increasing their steps by 1706 ± 698 steps/day which was more that the individual 
consultation and control groups (+ 837 ± 688, + 313 ± 493 steps/day respectively, p ≤ 
0.05). The group counseling participants also self-reported more total PA compared to 
the control group which showed a decrease (p ≤ 0.05). Waist circumference, BMI, and 
HbA1c changed significantly in the time-by-group analysis between the individual 
consultation group compared to the control (p ≤ 0.05). The group consultation appears 
to be effective at increasing steps/day while the individual consultation appears to have 
improved several health outcomes in the short-term.
15
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Summary 
All of the studies included in this review were published between 2004 and 2011 







 used a “usual care” control group compared to a pedometer-
based walking intervention, one study
20
 used a “usual care” control and two 
intervention groups, while the remaining studies compared two intervention groups. The 
study durations went from 6 weeks to 24 weeks with only two studies including post 




 All the studies in this review 
included two groups with 10 to 60 people in a group with an average of about 25 in 
each group. Ages of the participants ranged from 18-89 with an average age of 57. 












Important insights can be gained from the various intervention methods that 
were used to increase PA and affect health. All intervention groups received a 
pedometer and some type of logbook to record steps/day or major PA performed 
throughout each day. Additionally, all of the interventions included some form of 
personal or assisted goal setting and self-regulation techniques. These skills seem to be 
a crucial part in establishing consistent personal habits that will allow a behavior to be 
maintained over time. Group counseling was used in some of the studies
16-20
 as an 
effective means of increasing PA and creating an environment where participants would 
have opportunities for social interaction. Other studies included counseling sessions 








 or only the use of 
pedometer logs
108
 or computer aided motivational messages.
109
 Each intervention type 
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was able to produce increases in PA with or without a pedometer with the exception of 
one study.
23
 It may therefore be assumed that most types of interventions beyond the 
usual care for patients with T2DM will increase PA at least in the short-term. This could 
potentially be due to the novelty of the intervention or the specific attention the patients 
get during the intervention which might fade over time unless some continued contact is 
made. A pedometer might be one type of intervention to help T2DM patients track and 
increase their PA levels, but pedometers don’t seem to produce added benefits in greater 
amounts of PA or increased physiological benefits beyond other intervention 
techniques.
15
   
 The duration of the studies included in this review is relatively short and that 
could contribute to the significant increases in PA while making it difficult to detect 
differences in physiological measures. The shortest studies were six weeks
108,109
 and the 




 failed to find a 
significant change in HbA1c in the intervention group, two studies
21,109
 did not measure 
HbA1c, two studies
19,23
 recorded decreases in HbA1c in both intervention groups, and 
one study
20
 observed decreases in HbA1c in physician led counseling compared to a 
group led counseling intervention. Of the studies that saw significant differences, the 
interventions lasted for three or six months which indicates that shorter term studies 
may not be able to impact HbA1c in less than three months. Four interventions
16,17,20,108
 
measured, but did not cause significant decreases in fasting blood glucose levels, while 
five
18,19,21,22,109
 did not measure fasting glucose and one found a significant decrease in 
fasting glucose levels in both groups included in the study.
23
 These six-week to six-
month studies therefore do not produce evidence that pedometer-based walking 
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programs can effectively change blood HbA1c levels or fasting glucose levels to a 
significant degree. A longer duration, larger sample size, higher intensity, or addition of 
a dietary component may be necessary to produce and detect changes in glycemic 
measures though there are other additional benefits to increasing PA through walking.
15
 
Pedometers seem to help increase PA among T2DM patients, but not necessarily 
any more than other interventions. The most common type of pedometer used in these 
studies was the Yamax Digi-walker SW-200,
16,18-20
 with other types of Yamax 
pedometers
22,23,108
 and one type of Omron
109
 pedometer also used. Only three 
studies
21,108,109
 recommended 10,000 steps/day while the remaining studies encouraged 
a general increase in PA and setting individual goals to increase PA. When two 
intervention methods were compared
22,23
 with a pedometer group and a non-pedometer 
intervention, the addition of the pedometer did not add any additional benefit. 
Therefore, pedometers were effective intervention tools at increasing PA among these 
T2DM patients, but may not be needed if other intervention methods are available.
15
 
At least for the pedometer based walking studies in T2DM adults, there is only 
one
23
 that found changes in fasting blood glucose which was after only a month and 
they also found significant changes in HbA1c also only after a month and at three 
months compared to baseline. Another study
19
 found significant changes after three 
months while the remainder of the studies that measured HbA1c and glucose failed to 
find significant differences following a walking program. Several of the studies 
mentioned that they were underpowered and therefore could not detect significant 
changes in HbA1c if differences did occur.
16-18,22
 Based on the results from Tudor-
Locke, et al.,
16
 at least 84 participants would be needed to see a significant 0.5-1% 
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difference in HbA1c between groups while Araiza, et al.
108
 confirmed that 15 subjects 
was sufficient to find a significant reduction in HbA1c of 0.7% within the treatment 
group with 80% power and α = .05 by a paired t test.    
Motivation/Theory 
Theories Used in Health Psychology 
The use of theory can guide research and practice in social psychology, leading 
to more effective interventions and outcomes. Using complementary aspects of several 
theories can lead to a greater impact than pitting theories against each other, which can 
lead to fragmented knowledge about a certain behavior.
110
 The Theory of Reasoned 
Action, Theory of Planned Behavior, Health Belief Model, and the Transtheoretical 
Model have been cited as some of the most popular theories used in health psychology 
research.
111
 In a systematic review of health behavior research, 37.5% of the articles 
mentioned theory and the three most common theories used were Transtheoretical 
Model, Social Cognitive Theory, and Health Belief Model.
112
  
Social Cognitive Theory 
Social Cognitive Theory was developed by Albert Bandura and was made 
official in 1986 with his book, “Social Foundations of Thought and Action: A Social 
Cognitive Theory.” The core determinants set forth by Social Cognitive Theory include 
knowledge, perceived self-efficacy, outcome expectations, perceived facilitators, and 
impediments.
113
 It deals with the interaction of the person trying to change their 
behavior, the behavior they are trying to change, and the environment (reciprocal 
determinism). The self-efficacy and self-regulation constructs have been adopted by 
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several other theories such as Protection Motivation Theory and Health Belief Model, 
and have been powerful predictors and intervention techniques for behavior change.
114
    
Social Cognitive Theory and Walking Programs for Type II Diabetes 
Constructs from Social Cognitive Theory are used in many of the walking 
programs for T2DM patients. Self-control was targeted with goal setting and self-
management techniques such as using a behavior log and setting reasonable goals to 
work toward.
16-18,22,23,108
 As reasonable goals are made and progress is observed, a 
person’s self-efficacy increases due to success with a certain task.
115
 Behavioral 
capabilities are increased by increasing knowledge about a certain behavior and the 
determinants that affect it. This has been used in T2DM walking interventions through 
increased knowledge with instruction on the effects of exercise and nutrition on 
T2DM.
17,19
 The environment has also been affected by providing motivational messages 
and social support to individuals trying to change their behavior.
18,20-22
 As these social 





Social Cognitive Theory provided guidance for a theory-based approach to the 
current intervention. Building on constructs outlined in Social Cognitive Theory, 
intervention strategies were created that could help influence adoption of PA behaviors. 
Self-control, behavioral capabilities, self-efficacy, and environment were used in the 
current study, though only self-efficacy was measured because that is the main 
antecedent that was measured in similar interventions. The constructs were used in this 
study through various intervention methods described in the next section.   
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Chapter III: Methods  
The primary purpose of this study was to evaluate the effectiveness of a 12-
week walking program in increasing moderate/vigorous intensity walking and 
decreasing sedentary time in inactive adults with Type II Diabetes mellitus (T2DM). 
Secondary purposes were a) to determine whether a 12-week walking program 
increases self-efficacy related to exercise, walking, and taking breaks in sedentary time, 
and b) to determine whether a 12-week minimal contact walking program can improve 
blood glucose, hemoglobin A1c (HbA1c), and Total Cholesterol:HDL ratio in inactive 
adults diagnosed with T2DM. 
Participants 
After obtaining approval from the University of Oklahoma Institutional Review 
Board, participants were recruited from the Norman and Oklahoma City, Oklahoma 
areas. Men and women between 40 and 64 years of age with no physical limitations to 
walking were recruited. All participants had been diagnosed with T2DM for at least 
three months and were insufficiently active (<150 minutes of moderate intensity 
physical activity per week). Pregnant women and those with a pacemaker or who were 
on insulin treatment were excluded from the study, though they were allowed to be on 
other hypoglycemic medications. All participants completed the informed consent 
document and obtained permission from their primary care physicians or diabetes 
specialists before participating in the study.   
Recruitment 
Participants were primarily recruited from the University of Oklahoma Healthy 
Sooners organization via mass email to identify eligible university faculty and staff. 
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Participants also were encouraged to refer friends or family members that fit the 
inclusion criteria. All potential participants were subsequently screened through a 
telephone interview to ensure eligibility.     
Experimental Design 
 This was a 12-week pre-test, post-test experimental design with participants 
randomly assigned to a “Breaks Only” group (BG) or a standard of care (“Walking”) 
group (WG). Walking was used as the standard of care intervention (control group) 
because of the regularity with which walking is recommended to diabetic patients as a 
means of improving glucose control. The BG participated in an intervention that was 
designed to interrupt sedentary time by taking a break (at least two minutes of 
moderate/vigorous intensity activity) for every hour of sedentary time. The WG 
received a walking recommendation to reach 10,000 steps per day by walking for at 
least 30 minutes/day in intervals of at least 10 minutes. All measurements were taken 
prior to the intervention, during the final week of the 12-week program, and at three 
months follow-up. Physical activity also was measured at week seven to assess 
progress. The independent variables for this study were time and intervention group 
assignment. Dependent variables were clustered into three groups: (1) behavioral 
antecedents; (2) behavioral targets; and (3) clinical outcomes.  Behavioral antecedents 
included: (1) exercise self-efficacy; (2) walking self-efficacy; and (3) sedentary self-
efficacy. Behavioral targets included: (1) steps walked per day as measured by a sealed 
pedometer and MET minutes expended per week in physical activity; (2) minutes per 
day of moderate and vigorous physical activity (PA); and (3) minutes of sedentary time 
measured by accelerometer and survey. Clinical outcomes included: (1) fasting blood 
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A demographic survey (Appendix A) was administered online during the first 
PA measurement week in order to obtain contact information and descriptive data about 
each participant. The demographic information collected included age, gender, 
race/ethnicity, annual household income, level of education, marital status, and smoking 
status.  
Health History Questionnaires 
An online health history and eligibility survey was used to confirm that 
participants met the inclusion/exclusion criteria (Appendix B and Appendix C). 
Information included: (1) physical activity level, presence of any health issues that may 
cause inability to participate in a walking program (e.g., chest pain, dizziness, joint 
problems, or heart problems), (2) diagnosis of hypertension or hyperlipidemia, 
diagnosis of diabetes or heart disease; pregnant or planning to become pregnant, (3) 
presence of a pacemaker, and (4) family history of diabetes and/or cardiovascular 
disease. Each participant was also asked how long they had been diagnosed with 
diabetes and if they currently used insulin. They also listed all current medications 
(diabetic and other) at each visit to account for potential effects related to changes in 
type or dose of medications.  
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Food Frequency Questionnaire 
To ensure that diet remained constant throughout the intervention, a Food 
Frequency Questionnaire (FFQ) was administered online before and after each program. 
The FFQ (Appendix D) addresses food intake over the previous seven days and 
includes 14 items that ask how often certain foods are consumed. The specific areas of 
diet that were analyzed were cheese (portions per day or week), red meat (portions per 
week), canned fish (portions per week), deli meats (times per week), pizzas and pies 
(times per week), French fries (times per week), fruit juices (portions per week), nuts 
(yes or no), vegetables (portions per week), butter and cream (portions per day), oil (for 
cooking or as spread meals per day), and salad dressings (tablespoons per day). The 
FFQ has been tested against a seven-day Diet History and produced a moderate 
correlation with fruits and vegetables (r = 0.47) and a stronger, but still moderate 
correlation with polyunsaturated and saturated fatty acids (r = 0.63, p < 0.05).
116
 The 
average Spearman correlation coefficient for the FFQ compared to dietary recall was 
moderate (r = 0.54). The FFQ was also analyzed for test-retest reliability and produced 
a strong correlation between the two attempts (r = 0.81).
116
  
Twelve participants completed the FFQ at pre-testing and three of those 
participants failed to complete the FFQ at post-testing. A qualitative comparison was 
made from pre- to post-intervention for the specific dietary components that had a high 
fat content or a high glycemic index since these foods were most likely to affect the 
clinical outcomes that were monitored for this study. These included consumption of 
cheese, red meat, deli meats, pizza and pies, pastries and cakes, French fries, fruit/fruit 
juices, butter/creams/margarines, and oils. Two participants slightly increased cheese 
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consumption, two slightly decreased, and the rest of the participants did not report 
changes in cheese consumption after the intervention. One participant increased red 
meat consumption and one participant decreased red meat consumption. One participant 
slightly decreased deli meat consumption while the other participants did not report 
changes in deli meat consumption. Three participants increased and three participants 
decreased in their consumption of pizza and commercial sandwiches, while the other 
participants did not report changes. Most participants reported eating restaurant or fast 
food French fries both before and after the intervention. Two participants slightly 
decreased cake and pastry consumption while one increased. The remainder of the 
participants did not report changes in cake and pastry consumption. Several changes in 
fruit/fruit juice consumption were reported; four participants reported decreases in 
fruit/fruit juice consumption while three reported increases. Three participants slightly 
increased their consumption of butter and cream while one decreased, and the 
remaining participants did not report any changes in butter and cream consumption. 
Apart from butter and cream, two participants increased consumption of other fat 
spreads (e.g. margarine) on cooked meals while two decreased consumption. Three 
participants increased use of margarine or other oils in cooking. Results from the FFQ 
did not appear to indicate any systematic changes in dietary behaviors that might have 
made a significant impact on the clinical outcomes measured in this study. 
Self-Efficacy Questionnaires 
Self-efficacy is the perceived ability of a person to exercise control over a 
particular behavior and was described by Albert Bandura and implemented into his 
Social Cognitive Theory.
113
 Bandura argued that self-efficacy should be measured for a 
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 created a survey measuring exercise self-efficacy using 40 subjects who were 
interviewed about a behavior they were in the process of changing. Self-efficacy scales 
were developed and a factor analysis was used to extract overall concepts from the 
scales. Subsequently, a 12-question survey was developed to measure exercise self-
efficacy (Appendix E). This survey asks how confident a person would be to motivate 
himself/herself to perform certain exercise related behaviors consistently for the next 
six months and measures confidence for each behavior on a five-point Likert. The scale 
ranges from one to five with a score of one indicating low confidence to perform 
exercise in a variety of situations and five indicating high confidence at performing 
exercise in a variety of situations. Criterion validity was tested by comparing survey 
data with reported participation in vigorous PA (r = 0.32, 0.40 for exercise self-efficacy 
factors, p < 0.001). Higher scores indicated that higher participation in vigorous activity 
correlated with higher self-efficacy for that activity. Test-retest reliability for the survey 
was moderate for both of the exercise factors (r = 0.68, p < 0.001). Internal consistency 
was strong (Cronbach’s α = 0.83 and 0.85 for both factors). The Sallis instrument was 
used to measure exercise self-efficacy in this study. 
 Self-efficacy is conceptualized as specific to a certain behavior and 
generalizable to similar behaviors.
118
 If a specific behavior is targeted, a questionnaire 
should address self-efficacy related to that specific behavior. Therefore, additional self-
efficacy questionnaires were developed to measure self-efficacy related to vigorous 
walking (Appendix F) and interruption of sedentary behavior (Appendix G). These 
instruments were based on the Sallis Exercise Self-efficacy instrument, with the 
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changes made that were appropriate for each targeted behavior. All self-efficacy 
surveys were completed online. The internal consistency was acceptable for the 
exercise, walking, and “breaks in sedentary time” self-efficacy (Chronbach’s α = 0.924, 
0.868, 0.866, respectively for all pre-values). The exercise self-efficacy survey was used 
as the criterion with which to compare the other two surveys and the walking self-
efficacy survey was strongly correlated with the exercise self-efficacy survey (r = 
0.809). The breaks in sedentary time survey was moderately correlated with the exercise 
self-efficacy survey (r = 0.475).   
International Physical Activity Questionnaire – Long Form 
The International Physical Activity Questionnaire (IPAQ) is a widely used self-
report measure that assesses PA related to occupation, transportation, yard and garden, 
household, leisure time, and sitting time over the previous seven days. The IPAQ-long 
form (Appendix H) has been validated across 12 countries using 1880 participants and 
is able to be used to compare population health across countries.
90
 Test-retest reliability 
was very strong in most countries (Spearman coefficient = about 0.8).
90
 Criterion 
validity was measured against total activity as measured by an Actigraph accelerometer 
(N = 744 adults, pooled ρ = 0.33, 95% CI 0.26–0.39).
90
 A high correlation with 
accelerometry activity data would indicate that participants report similar amounts of 
PA compared to how much they actually get as measured by the accelerometer. This 
form was completed online before, after, and three-months following the program as a 
survey measure. This instrument has been used previously in a pedometer-based 
walking program for patients with T2DM.
21
 This measurement was used in addition to 
accelerometer measured PA as dependent variables in this study. 
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Blood Pressure 
Blood pressure was assessed for descriptive purposes using an electronic 
sphygmomanometer (Omron HEM-780, Kyoto, Japan). The participant was seated for a 
minimum of five minutes to allow blood pressure to stabilize at resting level. During 
measurement, the dominant arm (self-reported) was placed on a table at chest level. The 
lower edge of the cuff was applied about one inch above the antecubital space with the 
air bladder covering the brachial artery.
119
 Several participants were measured at the 
forearm due to inability to fit the cuff correctly around the upper arm. The cuff pressure 
was raised rapidly and slowly released until systolic and diastolic values were obtained. 
Two or more measurements were taken 30-60 seconds apart until two consecutive 
measurement within 5 mmHg for each value were obtained.
119
 The average of the 
values was recorded. A higher value indicated that there was a higher pressure built up 
in the blood vessels that may represent higher likelihood of vascular damage and 
disease development.    
Heart Rate 
Heart rate was measured for descriptive purposes at the same time as the blood 
pressure with the same machine as described above. Participants were required to be 
seated for at least five minutes prior to the measurement and they were instructed to 
relax while sitting upright in a padded chair. High resting heart rates indicate increased 
workload on the heart that over time may increase the risk for disease development.   
Height 
Height was assessed for descriptive data using a measuring tape attached to the 
wall. Participants were asked to remove their shoes, and then stand as tall as possible 
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while looking straight ahead with their heels together and their arms to their sides. They 
were then asked to take a deep breath and hold it until the horizontal bar was brought 
down to compress their hair and touch the highest point of their head.
119
 Measurements 
were taken to the nearest 0.5 inch. 
Weight 
Weight was measured as a component part of the BIA body composition 
assessment (as described in the next section) and as another descriptive measure. 
Participants were asked to remove their shoes and excess clothing, then step onto the 
BIA platform with both feet. They were asked to rest their arms at their sides and to 
look forward and remain still until a stable reading was obtained. Weight was recorded 
to the nearest 0.1 pound.     
Anthropometric Measures 
A tension loaded plastic tape measure was used to assess waist and hip 
circumferences for descriptive purposes. Waist circumference was taken at the smallest 
part of the waist below the rib cage and above the umbilicus while standing and 
relaxing the abdominal muscles. If no “smallest part” area around the waist existed 
above the umbilicus, then the measurement was taken at the level of the umbilicus.
119
 
Hip measurements were taken at the largest part of the hip-buttocks area while the 
participant was standing.
119
 All circumferences were taken at the right side of the 
participant. Waist to hip ratio was calculated by dividing the waist circumference by the 
hip circumference.  
 Body fat percentage was measured using bioelectrical impedance analysis, BIA 
(Tanita, BC-418, Tokyo, Japan). Participants placed both bare hands and feet on the 
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conduction points of the BIA device, then stood still with their hands relaxed, but not 
touching their sides. Body fat was measured to the nearest 0.1 percent with this machine 
and has been shown to measure 2-6% lower values for fat mass (in most people) 
compared to DXA.
120
 However, compared to DXA, this BIA method has also been 




A finger prick method was used by a qualified phlebotomist to obtain one drop 
of blood from each participant at pre-test, post-test, and three-month follow-up to 
measure fasting blood glucose, HbA1c, and total cholesterol/HDL ratios. All blood 
draws were performed using universal precautions provided by Blue Cross and Blue 
Shield. Blood cholesterol and glucose measures were analyzed using the Cholestech 
LDX System® (Alere Inc., Waltham, MA). This device has been validated for HDL and 
total cholesterol measurement, but information on glucose and HbA1c is not available.  
Step Count Measurement – Pedometer 
The pedometer used in this intervention (Yamax SW200, Tokyo, Japan) was 
relatively inexpensive (≈ $20 each) and has been frequently used in walking 
studies,
16,18,19,21
 as well as a criterion reference by which to compare other pedometers.
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In a previous study, the Yamax SW model gave mean step counts that were within 1% 
of actual steps at different walking speeds and was the only one out of 10 models that 
did not differ significantly from actual steps at five different walking speeds.
84
 It has 
also been shown to be reliable in normal weight, overweight, and moderately obese 
populations.
85
 The pedometer was used to measure daily steps for members of the WG 
during the entire intervention (Appendix I). In addition to the accelerometer, 
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pedometers were used to collect daily step counts in both groups during pre-, mid-, 
post-, and follow-up measures. 
Activity Monitor – Accelerometer 
The accelerometer used in this intervention (Actigraph GT1M, Pensacola, 
Florida) has been frequently used to measure step counts, energy expenditure, and 
minutes spent in various levels of PA. Accelerometers have previously been cited as the 
most often used direct measure of PA for studies that compared direct and indirect 
measures.
75
 They accurately measure all accelerations of the center of mass of the body 
and, unlike other measurement tools, produce information on acceleration that also can 
be processed to obtain speed and distance information.
77
 Although accelerometers 
produce high quality PA data, they are expensive and the data analysis is a more 
complicated process when compared to other simpler forms of PA measurement.
78
  
The GT1M accelerometer has been shown to be valid and reliable for adults 
during walking. Using the GT1M, counts and energy expenditure were highly 
correlated during graded walking at different speeds.
122
 The GT1M has also 
demonstrated reliability in measuring both counts (intra-instrument reliability 
coefficient of variation = 2.9%; inter-instrument reliability coefficient of variation = 
3.5%) and steps (intra-instrument reliability coefficient of variation = 1.1%; inter-
instrument reliability coefficient of variation = 1.2%).
123
 The data obtained from the 
accelerometers provides objectively measured minutes in moderate and vigorous PA 
and minutes of sedentary time (dependent variables). Accelerometer data were 
processed using ActiLife 6.0 software. The data were considered if the participant wore 
the accelerometer for a minimum of four days of the total seven and for ten hours each 
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day. They were told to wear the device during all waking hours and to remove it for 
water activities or sleeping. Non-wear time was excluded from the analysis. Sedentary 
time was classified as all minutes with 0-99 counts per minute and moderate to vigorous 
PA was classified as ≥ 1952 counts per minute.
124
 That number of minutes in PA and 
sedentary time was summed to obtain a total number of hours spent in sedentary time 
each week and averaged out for each valid measurement day. 
 Participants tracked breaks in sedentary time on a break log (Appendix J). 
Breaks also were calculated from accelerometry data. These breaks were only 
calculated for valid wear time with the accelerometer (at least four days of at least 10 
hours per day). In each case, a break was defined as values greater than 99 




Participants who met initial inclusion criteria were scheduled for a pre-test visit 
where the study details were explained. They completed the informed consent and 
HIPAA documents and were allowed to ask any questions concerning the study. They 
were given a medical clearance form to give to their physicians for clearance to 
participate in the study. Following the initial visit, participants completed several 
surveys prior to the second visit, including: the demographics survey, health history 
questionnaire, diabetes questionnaire, and eligibility form to ensure that they qualified 
for participation in the study. If participants qualified, they also completed the exercise 
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self-efficacy, walking self-efficacy, sedentary time self-efficacy, food frequency, and 
IPAQ questionnaires online (Qualtrics Survey Software, Provo, UT).  
Upon completion of the surveys and receipt of the medical clearance, 
participants were visited by one of the study researchers. Participants received a Yamax 
SW200 pedometer and Actigraph GT1M accelerometer and were instructed to wear 
them on the right side of the body in line with the center of the right leg, or they could 
move the devices around toward the rear of the right side depending on where an 
accurate pedometer reading could be taken. They practiced calibrating the pedometer by 
first setting it to zero, then walking 20 normal steps. They then checked to see how 
many steps were recorded on the pedometer. If the number of recorded steps deviated 
from the actual number taken, they were instructed to move the pedometer around the 
right side of the waistline until 20 steps were recorded on the pedometer after resetting 
it to zero and taking another 20 calibration steps.   
Once the participants felt comfortable calibrating the pedometer, they were 
instructed to wear it along with the accelerometer for the next seven days. They were 
instructed to calibrate the pedometer on the morning of the first day, take note of the 
appropriate pedometer position, and then place a sticker over the step count numbers on 
the pedometer so that they would not be able to read the number of daily steps taken 
during the measurement period. They wore the pedometers during all waking hours for 
the seven days, removing it only for water activities and sleep. They also were 
instructed to maintain their normal lifestyle during the seven days of PA measurement 
and that the walking program would begin following these initial PA measurement 
days.  
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Following the surveys and baseline PA measurement, participants met at a pre-
determined location for more measurements and to return their pedometers and 
accelerometers. Resting heart rate, blood pressure, height, weight, body composition, 
and waist and hip circumferences were measured by a member of the research team. 
Following a 12-hour fast, they received a finger prick from a qualified phlebotomist to 
obtain one drop of blood. Blood glucose, hemoglobin A1c, and a lipid panel were 
obtained from this blood sample. 
One final visit was made to each participant to explain the walking program. 
Participants were then randomly assigned to either the BG group or the WG by using a 
random number generator that created equal groups. The walking program was then 
explained to each participant assigned to the WG. The members of the WG received a 
pedometer so they could use it during the intervention. Both groups received behavior 
logs to track their progress in taking steps and breaks. The intervention began on the 
same day for everyone. For complete participant flow chart see Figure 1.    
Walking Group 
All participants began their assigned intervention following the pre-testing 
visits. The WG was instructed to calibrate the pedometer each day and to record the 
number of steps they took each day along with any unusual activities that may have 
created an abnormal step count (e.g., injuring an ankle or taking an unusually long walk 
or hike). They were emailed an electronic step log that was to be turned in at the end of 
each week. Each participant was asked to accumulate at least 10,000 steps/day through 
increasing PA. They were also asked to include a 30 minute block of moderate intensity 
walking (causing slight shortness of breath or mild onset of sweating) in bouts of at  
68 




least 10 minutes, but that would add up to at least 30 minutes/day. Participants were 
allowed to take their baseline number of steps as measured during pre-testing, then 
work up to 10,000 steps/day by adding 1,000 steps/day to that baseline number, 
building each week.  
Using Social Cognitive Theory constructs, intervention methods were 
developed. Self-control was developed by providing daily logs for participants to set 
goals and monitor their own behavior to progress in their number of steps each day. 
Instruction was given on how to make progress and strategies to increase activity in 
order to increase behavioral capability. Self-efficacy was targeted by making small 
changes each week to the number of steps so participants could see their progress. 
Participants recorded daily blood glucose levels in their behavior logs as they regularly 
should be doing for diabetes treatment and so they could see improvement. During the 
intervention, participants received a weekly email message (Appendix K) designed to 
increase exercise self-efficacy through social support and encouragement (vicarious 
experience and verbal persuasion). A follow-up email was sent each week to reinforce 
the motivational message that was introduced earlier in the week and to remind them to 
submit their weekly step logs. A Facebook page also was available for participants to 
log onto and interact with other participants in order to share successes and strategies  
that helped them succeed. Biweekly phone calls were made to all participants to assess 
program adherence and resolve any concerns. The phone call dialogues were typed as 
they were given in order to obtain qualitative data to help explain program results. 
Lastly, participants were encouraged to change their environment to promote activity, 
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such as setting reminders around themselves or setting their walk log near them to 
remind them to be more active.      
Breaks Group 
Before the first day of the program each member of the BG was emailed an 
electronic break log. They were instructed to stand up and perform at least two minutes 
of moderate intensity walking to break up every one-hour block of sedentary time 
(computer time, watching television, sitting at a desk, etc.). They were also sent weekly 
emails that included the additional information about sedentary behavior (Appendix L) 
and received a biweekly phone call similar to the one received by the WG. A separate 
Facebook group was also created for the BG so that they could interact with each other 
and provide social support. The same theory-based methods for behavior change used in 
the WG were used in the BG except focused on increasing breaks in sedentary time.   
Mid-test Visit 
During week seven of the intervention, all participants performed a mid-test PA 
measurement. Prior to week seven, both intervention groups received the same 
pedometer (blinded for BG) as well as the accelerometer that they used during the pre-
test measurements. During week seven, all participants wore the measuring devices 
during all waking hours of the day except during any water activities. The devices for 
the BG were returned at the end of the week The WG retained their pedometers for 
continued use.    
Post-test Visit 
Prior to week 12, participants returned and repeated the same procedures as 
during the initial visit with the exception of completing the informed consent and 
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HIPAA. After explaining the pedometer calibration process again, the participants 
repeated the PA measurement during the final seven days of the intervention using their 
assigned pedometers and accelerometers. They were then instructed to return the 
pedometers and accelerometers following the third measurement period during the 
health screening. The health screening followed immediately after week 12 was 
completed. All participants were allowed to keep their pedometers at the completion of 
the study as a “thank you” for their participation. 
Follow-up Visit 
Three months following the post-test visit, participants were contacted and all 
measurements that were performed during the post-test visit were repeated using the 
devices and equipment used during the previous testing sessions. 
Sample Size Estimation 
Sample size was estimated using results from previously conducted walking 
interventions in similar contexts to the current study. The variable least sensitive to 
change within the 12 week walking intervention was hemoglobin A1c (HbA1c) and was 





 walking studies in T2DM patients were used to 
calculate intervention treatment effects (Cohen’s d) of .82 and  1.16, respectively. This 
was done by calculating mean HbA1c differences and dividing that by the standard 
deviation of the initial measurement for the control group. Following procedures 
outlined for estimating effect sizes using GPower, the Cohen’s d values were divided in 
half to estimate the f value which was then inserted into GPower to estimate sample size 
using a within-between-factors, repeated measures ANOVA test with a power of 0.8, α 
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= 0.05, two groups, and two measurements.
125
 Using the more conservative sample size 
estimate for HbA1c, at least 14 total subjects were needed to produce an effect that 
could be statistically significant. This was confirmed in the post hoc analysis of a six-
week walking study that determined that 15 subjects in the intervention group was 
enough to observe a 0.7% decrease in HbA1c with a power of 80% and  α = 0.05 using 
a paired t test.
108
  
 The primary target variable in this intervention was PA as measured by 
steps/day and was also used to calculate sample size in order to ensure adequate power. 
Using a walking intervention with sedentary women and a similar design to the current 
study,
9
 a sample size estimation was determined using a within-between group factors, 
repeated measures ANOVA test with a power of 0.8, α = 0.05, two groups, and two 
measurements. After following the procedure outlined above, a total sample size of four 
was calculated as the minimum number of participants needed to observe significant 
differences in steps/day. With the combined information provided from the calculations 
above, it was determined that a final sample size of 16-20 in each group was adequate 
to produce statistically significant effects in all variables included in the study.  
Statistical Analyses 
All statistics were calculated using IBM SPSS Statistics software, version 19.0 
(SPSS Inc., Chicago, IL). Descriptive statistics were obtained using data from 
demographic and dependent variables for the 16 participants who were randomized into 
the intervention. Two-way, repeated measures ANOVA’s were used to examine the 
effect of increasing PA (steps and minutes in moderate/vigorous PA) and decreasing 
sedentary time on self-efficacy (walking, exercise, sedentary), fasting blood lipid levels 
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(Total/HDL), as well as glucose and HbA1c levels. Effect sizes were described using 
the partial eta squared statistic (small: partial η
2









 Process evaluation was performed at each point of measurement or intervention. 
At testing periods, a checklist was used to ensure important points were described to 
each participant and each measurement taken. In addition to checklists, emails were 
tracked and confirmation was received as to whether the email was successfully 
delivered to each participant. Further information was collected as participants were 
able to click on a link to declare that they had read the email. During phone calls the 
length of the call and a detailed description of the conversation were recorded 
simultaneously as the conversation took place.  
Questions to Consider 
1. Was everything accomplished at the pretest visit?  Were participants given all 
materials?  
2. Was the intervention explained with essential steps described in detail? 
3. Did participants come back seven days after measuring PA levels? 
4. Did participants turn in walking logs every week for 12 weeks? 
5. Were motivational and reminder emails sent and read? 
6. Were participants satisfied with the program? 
7. How many participants volunteered but were not eligible? 
8. How many participants dropped out?  Is there a significant difference in any 
study variable for those who dropped out versus those who stayed in?  
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9. Were there any aspects of the environment that may have influenced 
intervention implementation or study outcomes? 
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Chapter IV: Results and Discussion 
Descriptive Statistics 
Initial data were collected for 16 participants who met inclusion criteria and 
were randomized into one of the two intervention groups (eight participants in each 
group), a walking group (WG) and a sedentary breaks group (BG). Physical 
characteristics did not differ between groups at baseline using independent t-tests to 
compare groups for each variable using p > 0.05 (see Table 1). Most participants were 
female (81.3%) with the exception of two males in the BG and one male in the WG. All 
participants lived or worked on or around the University of Oklahoma (Norman or 
Health Science Center campus). The ethnic distribution of the participants was 50% 
White, 25% Black, 18.8% American Indian/Native Alaskan, and 6.2% Hispanic. 
Table 1. Physical Characteristics by Group at Baseline 
Variable Group
1




Resting Heart Rate WG 8 79.1 ± 8.8 0.088 0.931 
 BG 8 78.6 ± 13.5 (12.1)  
Systolic Blood Pressure WG 8 130.3 ± 22.2 0.476 0.608 
 BG 8 124.6 ± 20.7 (13.9)  
Diastolic Blood Pressure WG 8 82.3 ± 9.2 0.688 0.848 
 BG 8 81.3 ± 11.2 (13.5)  
Height (inches) WG 8 66.4 ± 3.1 0.686 0.591 
 BG 8 65.5 ± 3.3 (14.0)  
Waist Circumference (cm) WG 8 42.9 ± 8.3 0.439 0.565 
 BG 8 40.8 ± 6.0 (12.8)  
Hip Circumference (cm) WG 8 47.0 ± 6.8 0.030 0.306 
 BG 8 44.0 ± 4.2 (11.6)  
Waist/Hip Ratio WG 8 0.91 ± 0.12 0.930 0.883 
 BG 8 0.92 ± 0.11 (13.8)  
Body Fat Percentage WG 8 43.4 ± 7.2 0.443 0.533 
 BG 8 41.4 ± 5.8 (13.4)  
Body Mass Index (BMI) WG 8 33.9 ± 7.8 0.174 0.620 
 BG 8 32.2 ± 4.8 (11.6)  
Weight (pounds) WG 8 214.9 ± 63.0 0.198 0.515 
 BG 8 197.1 ± 40.9 (12.0)  
1
WG – Walking Group; BG – Breaks Group; *Equal variance not assumed 
76 
A majority of the participants (62.6%) earned $50,000 or more per year for their 
combined annual household income. The participants also had a relatively high 
educational status; 87.5% had some college or obtained a college degree. Additionally, 
10 of the participants were married. Demographic information is listed in Table 2 
below. Based on interaction with the participants, many of them worked in professions 
that required large amounts of sitting time each day (i.e. secretary). There were no 
differences at baseline between groups for any socio-demographic variables (p > 0.05 
for all variables). 
Table 2. Socio-Demographic Characteristics 
Variable Total Sample 
n = 16 
Walking Group 
n = 8 
Breaks Group 
n = 8 
Gender Male 3 (18.8%) 1 (12.5%) 2 (25%) 
Female 13 (81.3%) 7 (87.5%) 6 (75%) 
    
Race/Ethnicity    
White 8 (50%) 5 (62.5%) 3 (37.5%) 
Black 4 (25%) 2 (25%) 2 (25%) 
Native American/Alaskan 3 (18.8%) 1 (12.5%) 2 (25%) 
Hispanic 
 
Household Annual Income 
1 (6.2%)  1 (12.5%) 
Less than $10,000 1 (6.3%) 1 (12.5%)  
$15,000-20,000 1 (6.3%)  1 (12.5%) 
$25,000-35,000 4 (25%) 1 (12.5%) 3 (37.5%) 
$50,000-75,000 5 (31.3%) 2 (25%) 3 (37.5%) 
More than $75,000 5 (31.3%) 4 (50%) 1 (12.5%) 
 
Education 
   
High School Graduate 2 (12.5%) 1 (12.5%) 1 (12.5%) 
Some College 8 (50%) 6 (75%) 2 (25%) 
College Graduate 6 (37.5%) 1 (12.5%) 5 (62.5%) 
 
Marital Status 
   
Married 10 (62.5%) 6 (75%) 4 (50%) 
Divorced 3 (18.8%) 1 (12.5%) 2 (25%) 
Separated 1 (6.2%)  1 (12.5%) 
Never Married 2 (12.5%) 1 (12.5%) 1 (12.5%) 
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 During pretesting, baseline values for all research variables were obtained (see 
Table 3). Data were compared between groups using independent t-tests to ensure 
equality. All baseline variables were equal between groups at baseline except for 
sedentary self-efficacy (p = 0.020). Equality at baseline was controlled for through 
random group assignment and is essential for comparison between groups using 
analysis of variance (ANOVA).  
 
Table 3. Baseline Values for Study Dependent Variables 
Variable Group
1




Physical Activity WG 7 16.7 ± 7.8 -0.29 0.776 
(accel. MVPA minutes) BG 7 18.4 ± 13.4 (9.67)  
Physical Activity WG 8 4388 ± 1821 -0.64 0.532 
(pedometer steps) BG 8 4873 ± 1825 (14.0)  
Sedentary Hours WG 7 11.1 ± 1.3 -0.84 0.417 
(accelerometer) BG 7 11.6 ± 1.3 (12.0)  
Sedentary Time Breaks WG 7 5 ± 1.9 -1.13 0.280 
(accelerometer) BG 7 6 ± 1.9 (12.0)  
Exercise Self-Efficacy WG 8 4.3 ± 0.40 -1.13 0.280 
 BG 8 4.6 ± 0.52 (13.3)  
Walking Self-Efficacy WG 8 4.3 ± 0.43 -1.03 0.320 
 BG 7 4.5 ± 0.42 (12.8)  
Sedentary Self-Efficacy WG 8 4.3 ± 0.50 -2.87 0.020 
 BG 8 4.8 ± 0.16 (8.4)  
Fasting blood Glucose WG 8 134.3 ± 34.0 -0.76 0.462 
 BG 8 152.6 ± 59.2 (11.2)  
Hemoglobin A1c WG 8 7.4 ± 1.7 -1.22 0.245 
 BG 8 8.7 ± 2.6 (12.3)  
Total/HDL Cholesterol WG 8 4.0 ± 0.81 0.67 0.517 
 BG 8 3.8 ± 0.92 (13.8)  
1
WG – Walking Group; BG – Breaks Group 





 Accelerometry Measures 
The combined minutes (moderate and vigorous) of physical activity (PA) per 
day were assessed between and within groups using a repeated measures ANOVA that 
included baseline and post-intervention (week 12) measures. Six participants in the WG 
and six in the BG recorded measurements for the two time points and were included in 
the analysis (See Appendix M). There was a significant time effect [F (1) = 5.396, p = 
0.043], but no time-by-group interaction [F (1) = 1.403, p = 0.264] or group effect [F 
(1) = 0.598, p = 0.457] (see Table 4).  
Moderate to vigorous PA increased more in the WG compared to the BG. Mean 
values for the WG increased from 16 minutes of moderate/vigorous PA (MVPA) to 
41.8 minutes at week seven and stayed at 41.2 minutes during week 12 indicating that 
there was some impact of the program on activity levels despite a fall to 21.3 minutes of 
MVPA at the three-months follow-up. The BG slightly increased from 16.2 minutes of  
Table 4. Summary of Final ANOVA Model for Accelerometer Average 
Moderate/Vigorous Minutes of PA per Day by Group (Walking vs. Breaks) and 
Time (pre and post) 
 
 
Variable Source df 
 













   
    
 Group 1 416.667 416.667 0.598 0.457 0.108 0.056 
 Error 10 6968.167 696.817 - - - - 





   
    
 Time 1 1666.67 1666.67 5.396 0.043 0.555 0.350 
 Time*Group 1 433.50 433.50 1.403 0.264 0.189 0.123 
 Error 10 3088.833 308.883 - - - - 
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MVPA to 16.8 minutes from baseline to week seven, then increased to 24.3 and 28.8 
minutes at week 12 and the three-months follow-up, respectively.  
When individual scores are considered, the overall results can be better 
understood. As the intervention was initiated, all participants in the WG increased their 
time spent in MVPA dramatically, ranging from an increase of seven minutes to an 
increase of 52 minutes per day from baseline to week seven. About half of the members 
of the BG increased slightly and the other half decreased slightly in MVPA. At week 
12, all members of the WG slightly decreased minutes of MVPA from week seven, 
except for participant 22 who dramatically increased again. With the exception of one 
participant, all members of the BG increased MVPA or stayed the same from week 7 to 
12. These results fit the purpose of the study in increasing MVPA in the WG and only 
slightly in the BG. The results suggest that there might be a concurrent improvement in 
clinical variables in the WG, but potentially not as much in the BG.  
Results for both groups have been observed in previous research with sedentary 
adults. De Greef et al.
127
 found that the total PA (light, moderate, and vigorous) 
increased in both a “usual care” control and walking intervention groups following a 12 
week intervention with five counseling sessions. This intervention was similar to the 
one received by the WG. At one-year follow-up total PA decreased toward baseline 
values in the De Greef et al. study. However, this study did not include a component 
designed to increase breaks in sedentary time. A feasibility study with sedentary older 
adults (≥ 60yrs.) measured PA and breaks with accelerometers for an intervention 




 Neither study used participants with Type II Diabetes (T2DM), but both 
found decreases in sedentary time and Gardiner et al. found increases in daily breaks. 
Pedometry Measures 
The average steps per day were assessed between and within groups using a 
repeated measures ANOVA that included baseline and post-intervention measures. The 
post-measurement was missing for participant 21 so the mid-measurement value was 
inserted to assume that he/she maintained his/her same activity level through the 
intervention. Seven participants in the BG and four participants in the WG were 
included in the analysis (See Appendix N). There was no significant time-by-group 
interaction [F (1) = 1.100, p = 0.322], time effect [F (1) = 2.952, p = 0.120], or group 
effect [F (1) = 0.003, p = 0.959] (see Table 5).  
Table 5. Summary of Final ANOVA Model for Pedometer Average Steps per Day 
by Group (Walking vs. Breaks) and Time (pre and post) 
Variable Source df 
 













   
    
 Group 1 56989.651 56989.651 0.003 0.959 0.050 <0.001 
 Error 9 1.801E8 20007819.3 - - - - 





   
    
 Time 1 27601192.3 27601192.3 2.952 0.120 0.336 0.247 
 Time*Group 1 10284165.0 10284165.0 1.100 0.322 0.156 0.109 
 Error 9 84142566.8 9349174.09 - - - - 
 
Significant differences were likely not observed due to a small sample size that 
resulted in the study being underpowered (Power < 0.8). The effect sizes for the 
interaction and time effects were moderate (partial η
2
 > 0.10). Mean values for the WG 
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increased dramatically from 3182 steps per day to 6931 steps per day at post-testing 
indicating that there was some immediate impact of the program on activity levels in 
this group despite a fall to 2430 steps per day at three-months follow-up. The BG 
slightly increased from 4497 steps per day to 5404 steps per day from baseline to week 
12, then decreased to 4895 steps per day at three-month follow-up. These results are 
confirmed by MVPA data obtained with the accelerometer.  
One individual’s scores may have had a significant influence on results obtained 
for the pedometer data. This participant recorded 5,236 steps per day at week zero and 
increased to 17,931 steps per day at post-test. This unusually high value was not 
technically classified as an outlier, but the value was more than three times any other 
individual value for the WG at post-test. Only three members of the WG recorded valid 
pedometer data for the post-testing, which also makes the data less meaningful because 
of the small sample size.  
Members of the BG generally exhibited an increase in daily steps from pre- to 
post-test. Most participants recorded decreased steps at the three-month follow-up when 
compared to post-intervention data. This suggests that some type of continued 
intervention is necessary to keep participants motivated and aware of their activity 
levels in order to be maintained after the organized activities of the program/ 
intervention are complete. Maintenance of improved activity levels is important since 
health benefits take time to develop.  
These data are consistent with results from other pedometer-based walking 
programs. Multiple studies have illustrated a dramatic increase in daily steps as a 
walking program begins, perhaps due to the novelty of the program.
9,15,95
 Many walking 
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programs for patients with T2DM last from six weeks to six months; many include 
reminders and external prompts from program administrators. When this supervision is 
removed, many participants seem to fall back into former habits and return to their 
baseline levels of steps per day.
16
 However, one study did observe maintenance of step 
counts for one year after participation in a four-month minimal contact intervention 
based on motivational phone calls.
21
   
Daily steps were recorded by members of the WG every day as they attempted 
to achieve the recommended 10,000 steps per day. The average number of steps per day 
increased overall throughout the program for the WG as tracked by group members 
(Appendix O and Figure 2). However, the number of participants in the WG that 
consistently turned their logs decreased as the program progressed (Figure 3). The 
participants who turned in their logs were the participants who were more engaged in 
the program or who were more successful, as a result, the weekly averages for steps 
may have been artificially inflated. Participant 22, for example, was very enthusiastic 
and consistently had an average daily step count far higher than any other participant, 










Figure 2. Average Steps per Day on Walk Logs (Walking Group Only) 
 



















































Participants Reporting Weekly Steps 
84 
International Physical Activity Questionnaire 
The combined minutes of MVPA per week were assessed between and within 
groups using a repeated measures ANOVA that included baseline and post-test (week 
12) measures. Six participants in each group recorded measurements for the two time 
points and were included in the analysis (See Appendix P). There was no significant 
time-by-group interaction [F (1) = 2.957, p = 0.116], time effect [F (1) = 3.701, p = 
0.083], or group effect [F (1) = 0.356, p = 0.564] (see Table 6).  
Table 6. Summary of Final ANOVA Model for Moderate/Vigorous MET-Minutes 
per Week by Group (Walking vs. Breaks) and Time (pre and post)  
 
Significant differences were likely not observed because of the small sample 
size that resulted in the study being underpowered (Power < 0.8). The effect sizes for 
the interaction and time effects were relatively large for the time*group interaction and 
time effects (partial η
2
 = 0.228 and 0.270, respectively). Mean values for the walking 
group (WG) increased from 1,337.7 MET-minutes of MVPA per week to 13,786.8 
MET-minutes of MVPA per week during week 12, indicating that there was some 
impact of the program on the participant’s self-reported activity levels. The BG  
Variable Source df 
 














   
    
 Group 1 50723663.5 50723663.5 0.356 0.564 0.084 0.034 
 Error 10 1.424E9 1.424E8 - - - - 





   
    
 Time 1 2.593E8 2.593E8 3.701 0.083 0.413 0.270 
 Time*Group 1 2.071E8 2.071E8 2.957 0.116 0.343 0.228 
 Error 10 7.005E8 70054604.4 - - - - 
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increased slightly from 4,305.8 MET-minutes of MVPA to 5,003.5 MET-minutes per 
week from baseline to week 12. 
Due to the small sample size, individual results contributed much of the change 
in self-reported activity. In the WG, several of the participants initially reported only a 
few thousand MET-minutes per week and then following the program reported over 10, 
20, or 30 thousand MET-minutes per week following the program. Several of these 
values are far out of proportion compared to pedometer and accelerometer data, 
indicating that there may have been a perceived increase in activity when actual activity 
did not increase as much. Most of the participants reported less than 1,000 MET-
minutes per week before and after the program. About 500 MET-minutes per week is 
equal to 30 minutes of moderate intensity activity on five days per week. Half of the 
participants reported more than 500 MET-minutes at baseline, and all participants 
reported more than 500 MET-minutes at the end of the program. 
Two similar studies used the IPAQ to measure activity during a walking 
program for patients with T2DM. Both studies used the interview form of the IPAQ 
because of reports that the written form tends to produce over-reporting.
128
 Both studies 
found significant time*group interaction effects for MVPA for the intervention group 




 interventions. Using the interview 
version of the IPAQ rather than the self-report version that was utilized may have 





Total hours of daily sedentary time was compared between and within groups 
using a repeated measures ANOVA that included baseline and post-intervention 
measures. Six participants in each group recorded measurements for the two time points 
and were included in the analysis (See Appendix Q). There was no significant time-by-
group interaction [F (1) = 0.279, p = 0.609], time effect [F (1) = 1.798, p = 0.210], or 
group effect [F (1) = 2.162, p = 0.172] (see Table 7).  
Table 7.  Summary of Final ANOVA Model for Sedentary Hours per Day by 
Group (Walking vs. Breaks) and Time (pre and post) 
 
Significant differences were not likely observed because of a small sample size 
that resulted in the study being underpowered (Power < 0.8). The effect sizes for the 
interaction and time effects were relatively large (partial η
2
 > .13). Mean values for WG 
decreased slightly from 11.3 hours of sedentary time per day to 10.6 hours during week 
12, indicating that there was a potential impact of the program on hours of sedentary 
time despite the fact that the intervention received by this group did not specifically 
target reducing sedentary behavior. There was an increase back to baseline values at 
Variable Source df 
 











   
    
 Group 1 4.002 4.002 2.162 0.172 0.265 0.178 
 Error 10 18.507 1.851 - - - - 





   
    
 Time 1 1.815 1.815 1.798 0.210 0.229 0.152 
 Time*Group 1 0.282 0.282 0.279 0.609 0.077 0.027 
 Error 10 10.093 1.009 - - - - 
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three-months follow-up in the walking group. The BG slightly decreased from 11.9 
hours to 11.6 hours from baseline to week 12. Three months following the intervention, 
hours of sedentary time decreased again slightly to 10.5 hours per day for the BG.  
Similar results have been previously reported for inactive adults with T2DM. A 
study by De Greef et al.
127
 used a 12-week pedometer-based walking intervention to 
increase PA and decrease sedentary time. The program included five counseling 
sessions using educational and motivational strategies along with tracking of activity 
levels. Steps increased in the intervention group and not in the control following the 
intervention, while sedentary time decreased in the intervention group and not in the 
control. There were about 20 participants in each group, and the intervention was 
conducted in a hospital with the control group receiving usual care for treatment of 
diabetes. The additional resources included by De Greef et al. may have improved the 
effectiveness of this program. Also, larger sample size and better power increased the 
likelihood of documenting significant findings.  
International Physical Activity Questionnaire 
Self-reported daily sitting time (hours) was compared between and within 
groups using a repeated measures ANOVA that included baseline and post-intervention 
(week 12) measures. Six participants in the BG and seven participants in the WG 
recorded measurements for the two time points and were included in the analysis (See 
Appendix R). There was no significant time-by-group interaction [F (1) = 0.794, p = 
0.392], time effect [F (1) = 1.845, p = 0.202], or group effect [F (1) = 0.345, p = 0.569] 




Table 8.  Summary of Final ANOVA Model for Sitting Hours per Day by Group 
(Walking vs. Breaks) and Time (pre and post) 
 
Significant differences likely were not observed due to a small sample size that 
resulted in the study being underpowered (Power < 0.8). The effect size for the 
interaction time effect was relatively large (partial η
2
 > 0.13), while the interaction and 
group effects had smaller effect sizes (partial η
2
 < 0.07). Mean values for WG decreased 
slightly from 8.6 hours of sitting time per day to 8.2 hours from baseline to week 12. 
The BG decreased slightly more than the WG, changing from 10.5 hours per day to 8.3 
hours from baseline to week 12. This suggests that the breaks only intervention may 
have had more impact on participants’ self-report of sitting time than the walking 
intervention. De Greef et al. also did not observe significant differences in sitting time 
using the interview IPAQ before and after a 24 week pedometer-based intervention for 
adults with T2DM. There was poor compliance in completing the online survey in the 
current study even though they could do it at a convenient time for them. 
Breaks in Sedentary Time 
Total breaks in sedentary time were compared between and within groups using 
a repeated measures ANOVA that included baseline and post- measures. Six  
Variable Source df 
 





   
Sitting hours 
(IPAQ) 
Between Subjects    
    
 Group 1 6.868 6.868 0.345 0.595 0.084 0.030 
 Error 11 219.074 19.916 - - - - 




   
    
 Time 1 11.405 11.405 1.845 0.202 0.237 0.144 
 Time*Group 1 4.907 4.907 0.794 0.392 0.129 0.067 
 Error 11 67.989 6.181 - - - - 
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participants in each group recorded measurements for the two time points and were 
included in the analysis (See Appendix S). There was no significant time-by-group 
interaction [F (1) = 0.044, p = 0.838], time effect [F (1) = 2.168, p = 0.172], or group 
effect [F (1) = 3.816, p = 0.079] (see Table 9).  
Table 9.  Summary of Final ANOVA Model for Accelerometer Average Breaks in 
Sedentary Time per Day by Group (Walking vs. Breaks) and Time (pre 
and post) 
 
Significant differences likely were not observed due to a small sample size that 
resulted in the study being underpowered (Power < 0.8). The effect size for the 
interaction, time, and group effects were relatively large (partial η
2
 > .13). Mean values 
for WG decreased by about one break through week 12, but increased back to baseline 
values at the three-month follow-up. The BG slightly decreased by about one break 
from baseline to week 12 and continued to decrease until the three-month follow-up 
measure. 
This study did not produce evidence of the efficacy of a program designed to 
increase the number of breaks in sedentary time each day. Gardiner et al.
27
 found 
conflicting results in a study designed to assess the feasibility of a program designed to 
interrupt sedentary time in older adults. They found high satisfaction, high compliance,  
 
Variable Source df 
 





   
Breaks 
(accel.) 
Between Subjects    
    
 Group 1 15.042 15.042 3.816 0.079 0.423 0.276 
 Error 10 39.417 3.942 - - - - 




   
    
 Time 1 2.042 2.042 2.168 0.172 0.266 0.178 
 Time*Group 1 0.042 0.042 0.044 0.838 0.054 0.004 
 Error 10 9.417 0.942 - - - - 
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an increase in the number of breaks in sedentary time, and a significant decrease in  
sedentary time. However, the intervention was very involved and only lasted for one 
week. Additionally, most of the increases in breaks occurred after 7pm during sedentary 
time at home after work. This time is likely more under the control of the participant 
compared to taking breaks during the day at work. In the current study, participants 
were encouraged to take breaks throughout the day, especially during their long 
working hours when most of them were sitting at a desk most of the time. Participants 
also kept “break logs” where they marked each time they took a two-minute break in 
their sedentary time throughout the day. In response to participant feedback, it appeared 
to be a tedious task to mark every time a participant took a break every day for the 
duration of a 12 week intervention. 
Self-Efficacy 
Exercise Self-Efficacy 
Average exercise self-efficacy values were compared between and within 
groups using a repeated measures ANOVA that included baseline and post-intervention 
(week 12) measures. Four participants in the BG and five participants in the WG 
recorded measurements for the two time points and were included in the analysis (See 
Appendix T). There was no significant time-by-group interaction [F (1) = 0.915, p = 
0.371], time effect [F (1) = 2.100, p = 0.191], or group effect [F (1) = 0.207, p = 0.663] 






Table 10.  Summary of Final ANOVA Model for Exercise Self-Efficacy by Group 
Walking vs. Breaks) and Time (pre and post) 
Variable Source df 
 










   
    
 Group 1 0.067 0.067 0.207 0.663 0.068 0.029 
 Error 7 2.275 0.325 - - - - 





   
    
 Time 1 1.157 1.157 2.100 0.191 0.241 0.231 
 Time*Group 1 0.504 0.504 0.915 0.371 0.132 0.116 
 Error 7 3.856 0.551 - - - - 
         
 
Significant differences likely were not observed due to a small sample size that 
resulted in the study being underpowered (Power < 0.8). The effect size for the time 
effect was relatively large (partial η
2
 > 0.13), while the time*group interaction and 
group effects were moderate to small (partial η
2
 = 0.116 and 0.029, respectively). Mean 
values of exercise self-efficacy for WG stayed almost the same from baseline to post-
test, while the exercise self-efficacy of the BG decreased (week 0 = 4.9, week 12 = 4.1). 
Due to the small sample size it is difficult to draw conclusions for self-efficacy. 
However, based on phone calls with the participants and the follow-up interviews, the 
beginning of the program was new and exciting for the participants. They initially were 
motivated to do something challenging. As the program progressed, they found it more 
difficult to keep up with the logs and reported feeling unsuccessful in their efforts to 
comply with the recommendations for their respective interventions. In comparison, one 
eight-week counseling intervention in Mexican Americans showed small increases in 
self-efficacy in both an intervention group and a usual-care control group, but these 





Average walking self-efficacy values were compared between and within groups 
using a repeated measures ANOVA that included baseline and post-intervention (week 
12) measures. Four participants in the BG and six participants in the WG recorded 
measurements for the two time points and were included in the analysis (See Appendix 
U). There was no time-by-group interaction [F (1) = 0.086, p = 0.777], time effect [F (1) 
= 5.143, p = 0.053], or group effect [F (1) = 0.814, p = 0.393] (see Table 11). 
Table 11.  Summary of Final ANOVA Model for Walking Self-Efficacy by Group 
(Walking vs. Breaks) and Time (pre and post) 
 
Significant differences likely were not observed due to a small sample size that 
resulted in the study being underpowered (Power < 0.8). The effect size for the time 
effect was relatively large (partial η
2
 > 0.13), while the time*group interaction and 
group effects were small and moderate (partial η
2
 = 0.011 and 0.092, respectively). 
Mean values for walking self-efficacy of both groups decreased from baseline to post-
test (WG: week 0 = 4.4, week 12 = 3.8; BG: week 0 = 4.7, week 12 = 3.9). This survey 
was created for the purpose of the current study because self-efficacy is behavior-
specific. There were, however, not enough participants to validate the survey. 
Variable Source df 
 










   
    
 Group 1 0.197 0.197 0.814 0.393 0.126 0.092 
 Error 8 1.937 0.242 - - - - 





   
    
 Time 1 2.279 2.279 5.143 0.053 0.514 0.391 
 Time*Group 1 0.038 0.038 0.086 0.777 0.058 0.011 
 Error 8 3.545 0.443 - - - - 
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Sedentary Self-Efficacy 
Average sedentary self-efficacy values were compared between and within 
groups using a repeated measures ANOVA that included baseline and post-intervention 
(week 12) measures. Five participants in the BG and six participants in the WG 
recorded measurements for the two time points and were included in the analysis (See 
Appendix V). There was no time-by-group interaction [F (1) = 0.086, p = 0.776] or 
group effect [F (1) = 3.835, p = 0.082] (see Table 12). There was however, a significant 
decrease in sedentary self-efficacy over time [F (1) = 10.396, p = 0.010]. The means 
significantly decreased following the intervention, although the “equality of groups” 
assumption was broken because the baseline means between groups were significantly 
different (See Table 3).  
Table 12.  Summary of Final ANOVA Model for Sedentary Self-Efficacy by Group 
(Walking vs. Breaks) and Time (pre and post) 
Variable Source df 
 










   
    
 Group 1 0.971 0.971 3.835 0.082 0.417 0.299 
 Error 9 2.279 0.253 - - - - 





   
    
 Time 1 2.224 2.224 10.396 0.010 0.818 0.536 
 Time*Group 1 0.018 0.018 0.086 0.776 0.058 0.009 
 Error 9 1.926 0.214 - - - - 
 
Significant differences between groups likely were not observed due to a small 
sample size that resulted in the study being underpowered (Power < 0.8), except for the 
time effect (Power = 0.818). The effect size for the time effect was relatively large 
(partial η
2
 > 0.13), while the time*group interaction had a small effect size (partial η
2
 <  
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0.01), and the group effect was also large (partial η
2
 > 0.13). Mean values of sedentary 
self-efficacy for both groups decreased from baseline to post-test (WG: week 0 = 4.4, 
week 12 = 3.8; BG: week 0 = 4.9, week 12 = 4.2). The significant decrease over time 
was likely due to the fact that the participants experienced difficulty in actually taking 
the number of breaks that the intervention recommended through the day and because 
taking breaks interrupted their focus at work. This survey also was created for the 
purpose of the current study because self-efficacy is behavior specific. However, there 
were not enough participants to validate the survey. 
Blood Glucose Control 
Blood Glucose 
Average fasting blood glucose values were compared between and within 
groups using a repeated measures ANOVA that included baseline and post-intervention 
(week 12) measures. Seven participants in the BG and six participants in the WG 
recorded measurements for the two time points and were included in the analysis (See 
Appendix W). There was no significant time-by-group interaction [F (1) = 0.040, p = 
0.845], time effect [F (1) = 0.356, p = 0.563], or group effect [F (1) = 0.939, p = 0.353] 
(see Table 13). 
Significant differences likely were not observed due to a small sample size that 
resulted in the study being underpowered (Power < 0.8). The effect size for the time 
effect was moderate (partial η
2
 > 0.06), while the time*group interaction and group 
effects were small (partial η
2
 = 0.004 and 0.079, respectively). Mean values of fasting 
blood glucose for both groups decreased from baseline to post-test (WG: week 0 = 
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129.7mg/dL, week 12 = 124.5; BG: week 0 = 154.7, week 12 = 152.1), but the decrease 
was greater for the WG. This could be due to greater program adherence in the WG  
Table 13.  Summary of Final ANOVA Model for Fasting Blood Glucose by Group 
(Walking vs. Breaks) and Time (pre and post) 
 
compared to the BG or simply that increasing PA is more related to glucose control than 
interruption of sedentary time.  
 Physical activity did appear to have an impact on blood glucose control for these 
participants. Not all participants who completed PA measurements were able to make 
each of the health screening to get blood glucose measured. Those who completed all 
measures showed mixed results. Regardless of group membership, some participants 
increased MVPA during pre-, mid-, and post- measurements while fasting blood 
glucose stayed the same or increased (participants 2, 15, 21). Others increased MVPA 
and decreased blood glucose (participants 7, 11, 16, 22). A larger sample size may have 
produced less equivocal results.  
 Overall, mean values of fasting glucose for both groups decreased slightly from 
pre-test to post-test, but not significantly. A similar decrease in fasting blood glucose 
was observed in the combined data of pedometer and non-pedometer walking groups at 
Variable Source df 
 











   
    
 Group 1 4484.770 4484.770 0.939 0.353 0.144 0.079 
 Error 11 52517.85 4774.350 - - - - 





   
    
 Time 1 96.726 96.726 0.356 0.563 0.085 0.031 
 Time*Group 1 10.880 10.880 0.040 0.845 0.054 0.004 
 Error 11 2987.27 271.570 - - - - 
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one month into a walking program, and the improvement was maintained through the 
duration of the six-month program.
23
 A similar 12-week randomized controlled trial 





Average hemoglobin A1c (HbA1c) values were compared between and within 
groups using a repeated measures ANOVA that included baseline and post-intervention 
(week 12) measures. Seven participants in the BG and seven participants in the WG 
recorded measurements for the two time points and were included in the analysis (See 
Appendix X). There was no significant time-by-group interaction [F (1) = 0.115, p = 
0.741] or group effect [F (1) = 1.226, p = 0.290], but there was a significant decrease in 
HbA1c over time [F (1) = 5.834, p = 0.033] (see Table 14). 
Table 14.  Summary of Final ANOVA Model for Hemoglobin A1c by Group 
(Walking vs. Breaks) and Time (pre and post) 
 
Significant differences likely were not observed for the interaction and group 
effect due to a small sample size that resulted in the study being underpowered (Power 
< 0.8). The effect size for the time effect was large (partial η
2
 > 0.13), while the effect 
size for group was moderate (partial η
2
 > 0.06) and the time*group interaction was 
Variable Source df 
 





   
HbA1c Between Subjects        
 Group 1 7.929 7.929 1.226 0.290 0.175 0.093 
 Error 12 77.627 6.469 - - - - 




   
    
 Time 1 17.443 17.443 5.834 0.033 0.603 0.327 
 Time*Group 1 0.343 0.343 0.115 0.741 0.061 0.009 
 Error 12 35.879 2.990 - - - - 




 = 0.009). Mean values of HbA1c for both groups decreased from 
baseline to post-test (WG: week 0 = 7.5%, week 12 = 6.2%; BG: week 0 = 8.8%, week 
12 = 7.0%).  
 There was a significant decrease over time for HbA1c for both groups 
combined. Individual results are difficult to interpret because some participants have 
drastic changes in HbA1c while others had smaller changes, which were not related to 
MVPA measured pre- and post- intervention. Participant 22 increased MVPA far 
beyond any other participant, yet had an increase in HbA1c of 1.5%. However, blood 
glucose dropped significantly across the same measuring points for the same 
participant. Another member of the WG (participant 21) who significantly increased 
MVPA also had an increase in HbA1c of 0.6%. The blood glucose also increased 
slightly for this participant. Participant 18 in the WG increased MVPA by only four 
minutes per day from pre- to post-intervention, yet had a 4.7% decrease in HbA1c. A 
participant in the BG (participant 17) recorded a slight decrease in MVPA following the 
intervention, but showed a 4.2% decrease in HbA1c. The reliability and validity of the 
HbA1c measurement technique for this study has not been established and may not 
compare to a standard blood draw method. 
 Mean changes for HbA1c were similar to those in some previous literature. 
Following one three-month intervention, the combined total for HbA1c decreased by 
1.6% from pre- to post-test. In another study, participation in a pedometer-based 
walking intervention was associated with a 1.6% decrease in HbA1c, which was 
statistically significant.
19
 Another study found a 0.32% decrease in HbA1c following 
participation in a 12-week pedometer-based walking program that included individual 
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consultation for patients with T2DM. However, these findings were not statistically 
significant.
20
 Likewise, the results from a 12 week walking program that involved 




Relationships between Predictors and Outcomes 
The relationship between predictor and outcome variables was not assessed due 
to a failure to find significant changes in either group of variables.  
Total to HDL Cholesterol Ratio 
Average cholesterol ratios (Total/HDL) were compared between and within 
groups using a repeated measures ANOVA that included baseline and post-intervention 
(week 12) measures. Seven participants in the BG and six participants in the WG 
recorded measurements for the two time points and were included in the analysis (See 
Appendix Y). There was no time-by-group interaction [F (1) = 0.043, p = 0.840], time 













Table 15.  Summary of Final ANOVA Model for Cholesterol Ratio (Total/HDL) by 
Group (Walking vs. Breaks) and Time (pre and post) 
 
 
Significant differences likely were not seen due to a small sample size that 
resulted in the study being underpowered (Power < 0.8). The effect size for the time 
effect was large (partial η
2
 > 0.13), while the time*group interaction and group effects 
were small (partial η
2
 = 0.004 and 0.001, respectively). Mean values of cholesterol 
ratios for both groups increased from baseline to post-test (WG: week 0 = 3.9, week 12 
= 4.3; BG: week 0 = 3.8, week 12 = 4.3), but these increases were not statistically 
significantly. 
Summary of Results 
 A summary of the quantitative results included in the statistical analysis is 






Variable Source Df 
 











   
    
 Group 1 0.011 0.011 0.006 0.938 0.051 0.001 
 Error 11 19.324 1.757 - - - - 





   
    
 Time 1 1.015 1.015 3.115 0.105 0.364 0.221 
 Time*Group 1 0.014 0.014 0.043 0.840 0.054 0.004 
 Error 11 3.586 0.326 - - - - 
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Table 16. Baseline Values for Study Variables 
Variable Group
1




Physical Activity WG 6 16.0 (8.3) 41.2 (37.8) 
(accel. MVPA minutes) BG 6 16.17 (13.1) 24.3 (18.4) 
Physical Activity WG 4 3181.5 (1740.7) 6931.3 (7532.7) 
(pedometer steps) BG 7 4497.0 (1330.6) 5404.1 (3518.5) 
Sedentary Hours WG 6 11.3 (1.2) 10.6 (1.6) 
(accelerometer) BG 6 11.9 (1.1) 11.6 (0.76) 
Sedentary Time Breaks WG 6 5.0 (2.1) 4.3 (1.4) 
(accelerometer) BG 6 6.5 (1.8) 6.0 (0.63) 
Exercise Self-Efficacy WG 5 4.4 (0.43) 4.3 (0.86) 
 BG 4 4.9 (0.14) 4.1 (0.89) 
Walking Self-Efficacy WG 6 4.4 (0.39) 3.8 (0.85) 
 BG 4 4.7 (0.29) 3.9 (0.54) 
Sedentary Self-Efficacy WG 6 4.4 (0.52) 3.8 (0.56) 
 BG 5 4.9 (0.08) 4.2 (0.56) 
Fasting blood Glucose WG 6 129.7 (37.9) 124.5 (22.0) 
 BG 7 154.7 (63.7) 152.1 (60.0) 
Hemoglobin A1c WG 7 7.5 (1.8) 6.2 (2.1) 
 BG 7 8.8 (2.8) 7.0 (1.8) 
Total/HDL Cholesterol WG 6 3.9 (0.67) 4.3 (1.1) 
 BG 7 3.8 (0.96) 4.3 (1.2) 
1 
WG – Walking Group, BG – Breaks Group 
 
Process Evaluation 
 Detailed records were kept through the duration of the study to evaluate the 
effectiveness of how the intervention was implemented. During the pretest visit, a 
checklist was made and kept for each visit for all participants. Important items of 
instruction and distribution of pedometers, accelerometers, and activity logs were 
tracked directly following each pretest visit. All participants received all materials and 
instruction as intended, and if any instructional points were missed, they were emailed 
to the participant later that same day. Emails were tracked with a time and date for each 
participant for each intervention point and reminder. Weekly motivational emails were 
tracked to ensure delivery and to determine whether participants read each email. All 
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emails were confirmed to be delivered and a majority of them were confirmed as “read” 
by participants. The number of participants confirming that they read the emails tapered 
off as the program progressed and only about two to three participants consistently 
responded throughout the intervention to questions asked in the emails about self-
efficacy and goals for improvement. 
 Accelerometers and pedometers were collected by the researcher or dropped off 
at the lab by participants. Most devices were received on the day appointed for 
collection after each measurement period. Two participants were required to wear the 
devices again during pre- and mid-testing due to insufficient wear-time or invalid data. 
At post-testing, three participants turned in measurement devices a month or more 
following measurement because of environmental and/or personal circumstances.  
 It appeared to be a difficult task for participants to turn in the walk and break 
logs throughout the study. There was a linear decrease in the number of participants 
who turned in walk logs over the duration of the study. This may have been due to the 
amount of effort required to write down total steps and breaks taken throughout the day 
and to email this log each week to the researchers. A more efficient tracking system that 
automatically tracks and transmits PA levels may address this issue in future studies.  
 Phone calls were made every other week during the intervention and interviews 
were conducted at the conclusion of the study. Of the 16 participants remaining at the 
conclusion of the study, six turned in the exit interview survey and comments were very 
brief. It appeared that throughout this intervention, the use of emails and online surveys 
were less effective than in-person contacts. It would take more time to administer 
surveys and interviews in person, but when participants in this study were allowed to 
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complete them on their own time, the quality and completion rates were significantly 
lower than rates obtained during pilot testing. 
 Participants were generally satisfied with the intervention, but stated that it was 
hard to make time to meet the recommendations for the total amount of steps and breaks 
every day. Twenty-two participants volunteered and were eligible for the intervention. 
Six participants dropped out of the program due to non-compliance, personal injury, or 
inability to complete the entire program. During post-testing, inclement weather 
prevented three participants from completing post-test measures. Also, as the study 
began early in the year, it was cold and participants commented that it was difficult to 
walk outside because of the temperature. As the weather improved during the study, 
participants seemed more excited to get out and be active. 
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Chapter V: Conclusions 
Hypotheses 
 The Research Hypotheses included: 
HR1: Participation in a 12-week minimal contact walking program for 12 weeks 
will result in a significantly greater increase in measures of self-efficacy 
(exercise and walking) pre- to post-intervention as compared to a 12-week 
breaks only intervention in inactive T2DM patients, while participation in a 
breaks only intervention will significantly increase measures of sedentary 
break self-efficacy pre- to post-intervention compared to a 12-week minimal 
contact walking program in inactive T2DM patients. 
HR2: Participation in a 12-week minimal contact walking program will result in a 
significantly greater increase in the number of steps/day, minutes in 
moderate and vigorous intensity PA, MET minutes associated with PA 
compared to a 12-week breaks only intervention in inactive T2DM patients, 
while participation in a breaks only intervention will significantly decrease 
sedentary time pre- to post-intervention compared to a 12-week minimal 
contact walking program in inactive T2DM patients. 
HR3: Participation in a 12-week minimal contact walking program will result in a 
significantly greater decrease fasting blood glucose, HbA1c, fasting blood 
lipids (Total/HDL) pre- to post-intervention as compared to a 12-week 
breaks only intervention in inactive T2DM patients. 
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HR4: If there is a significant change in PA and sedentary time from pre-to post-
intervention, exercise and walking self-efficacy will predict changes in PA 
level and sedentary self-efficacy will predict changes in sedentary time. 
 
 The null hypothesis was retained for all research questions except for changes in 
MVPA measured by accelerometer (time), sedentary break self-efficacy (time), and 
Hemoglobin A1c (time). Physical activity measured by accelerometer, combined across 
groups, increased following both interventions while pedometer and survey measured 
PA did not change. Sedentary break self-efficacy was significantly decreased for both 
groups combined, while the exercise and walking self-efficacy did not change. 
Hemoglobin A1c was significantly decreased across both groups combined following 
both interventions, while fasting glucose and total:HDL cholesterol did not change.  
Failure to identify significant differences between groups could have been due to an 
insufficient sample size, possible lack of adherence to all study protocols, and failure to 
complete all testing requirements. 
Strengths and Limitations 
 There were many strong points to this 12-week walking intervention. A study 
that included the two intervention groups used in this study had not been attempted 
previously in participants with T2DM. Because of this, study results could be useful in 
understanding alternative methods of intervention to improve glycemic control. This 
minimal contact program did not require an extensive staff to administer the program, 
which is important for reducing time and costs in treating large numbers of patients. 
The design was community-based and could easily be replicated in a workplace or 
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hospital setting. The design also allowed for all participants to participate in an 
intervention group as opposed to being randomized to a no-intervention, control group 
condition. 
 There were several limitations to this study that should be considered when 
planning future interventions. The three-month follow-up measure occurred on the first 
week of the fall semester, when many of the participants were highly involved in the 
academic environment. Because of that, data collected at that time point may not 
represent a normal lifestyle. Seasonal changes such as cold temperatures and tornadoes 
cannot be controlled, but did influence measurements and participation in the program. 
On the first day of post-testing a tornado in a neighboring city prevented two 
participants from being able to obtain their post-intervention measurements.  
Additionally, having some form of incentive could have allowed for a higher number of 
participants and increased retention and program adherence. Access to additional 
participants may have allowed for inclusion of a no-intervention control group. This 
was difficult because the blood draws were sponsored and paid for by the Healthy 
Sooners program and were therefore used to support OU faculty and staff and not other 
surrounding community members. This also required that blood draws were taken on 
pre-determined days, which prevented a rolling enrollment. 
Significance of Study 
 This study was meaningful because it was the first to test the possible effect of 
an intervention that was designed to break up sedentary time in patients with T2DM 
compared to a “standard care” intervention (i.e. walking). A one-week feasibility study 
has been conducted to increase breaks in sedentary time, but this study assessed 
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feasibility and impact of a three-month intervention with breaks assigned throughout the 
entire day for all sedentary time. Implications from this study could help guide future 
interventions focused on decreasing sedentary time in a manner more suitable to 
participants and/or allowing for additional options to intervene beyond a standard 
walking program. 
Recommendations 
 Results from this 12-week walking intervention provide useful insights that can 
be applied in future programs. Physical activity as measured using multiple methods 
can be increased with a minimal contact walking program, but finding methods to 
facilitate maintenance of activity consistently throughout the entire program is essential. 
Methods of tracking behavior should be improved to minimize workload on participants 
and to allow for provision of more individualized feedback and motivation. Sending the 
same messages to everyone through emails did not appear to be effective because many 
of the participants said they became monotonous and they did not choose to look at 
them anymore. 
Decreasing sedentary time may be less effective in impacting clinical outcomes 
than increasing PA. Many of the participants worked for a majority of the day at jobs in 
which taking many breaks to walk was not feasible. In phone conversations and 
interviews, they spoke about the stress of always thinking about the timing of their next 
break, which turned out to be a distraction. An alternative method may be needed to 
increase breaks during sedentary time.  
By making the program more effective, the clinical and psychosocial variables 
would be more likely to improve significantly. If participants are able to consistently 
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meet their intervention’s recommendations and protocols (either increase PA or 
decrease sedentary time), they would be more likely to be able to improve their blood 
glucose and HbA1c levels. These study participants with T2DM were willing and 
excited to participate in this intervention and wanted to improve their health. Taking 
their suggestions and concerns into account when redesigning the intervention for future 
implementation and testing may produce more effective results.  
Future Research Directions 
 Conclusions and recommendations from this study may help guide future 
research involving interventions designed to increase PA and/or decrease sedentary time 
in individuals with T2DM. Future interventions should be designed so that record 
keeping and behavioral tracking require less work on the part of the participants. This 
may result in better adherence. These changes could include the use of technology to 
track and transmit data from participants to a central database where that data could be 
viewed in real-time by the participant and the intervention/program staff. For example, 
devices such as the Jawbone UP25 and fitbit automatically transmit activity data via a 
smart phone to a central data site. These data can be viewed by the person wearing the 
device and may be shared with others. Future studies should provide compensation for 
participants in order to add incentive to both joining and remaining in the study so that 
an adequate sample size can be established.  
Giving members of the BG a specific goal in terms of number of breaks/day and 
the length of breaks instead of just a recommendation to take breaks every hour of 
sitting time may also increase compliance. Taking breaks during sedentary time after 
work (i.e. watching television, computer time, etc.) may be easier to manage than taking 
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breaks during the busiest times when people are at their jobs. Specifically, the 
intervention could be modified to recommend fewer but longer breaks during the 
working day.  
Including participants in a pre-intervention focus group may also allow for 
increased adherence by allowing participants to suggest specific strategies that they 
would be willing to follow. Continued research will lead to more time and cost effective 
strategies to improve health and quality of life outcomes for patients with T2DM.  
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Appendix A: Demographics Survey  
 
Demographics Survey 
Please answer the following questions honestly and to the best of your ability.  
1. What is your current age?  _____ 
2. What is your gender? 
a. Male 
b. female 
3. What do you perceive to be your ethnicity? (Check all that apply) 
a. White 
b. Black or African American 
c. Asian 
d. Native Hawaiian or Other Pacific Islander 
e. American Indian or Native Alaskan 
f. Hispanic or Latino 
4. What is your annual household income from all sources? 
a. Less than $10,000 
b. $10,000 to less than $15,000 
c. $15,000 to less than $20,000 
d. $20,000 to less than $25,000 
e. $25,000 to less than $35,000 
f. $35,000 to less than $50,000 
g. $50,000 to less than $75,000 
h. $75,000 or more 
5. What is the highest grade or year of school you completed? 
a. Never attended school or only attended kindergarten 
b. Grades 1-8 (elementary) 
c. Grades 9-11 (some high school) 
d. Grade 12 or GED (High school graduate) 
e. College 1 year to 3 years (some college) 
f. College 4 years or more (college graduate) 





e. Never married 
f. Member of an unmarried couple 
7. Do you currently smoke?          YES          /             NO  
a. If YES, how many years have you smoked? _________ 
i. If you have quit smoking, how many years did you smoke _________ 
ii. How many months/years ago did you quit? _________ 
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Appendix B: Health History Form 
Health History Form 
Functional Performance Laboratory 
Department of Health & Exercise Science - University of Oklahoma 
 
ID#: __________________________    Date: __________________________ 
 Gender   M   F                                        Age: __________________________ 
Please consider each question carefully and answer every question 
honestly. 
1.  In general how would you describe your current, overall state of health? 
   a. Excellent                                                           b. Good 
 c. Fair                                                                   d. Poor  
2.  Do you currently have any of the following have been diagnosed by health 
professional? 
    a. Heart trouble    i. Diabetes 
    b. Chronic asthma or bronchitis    j. Foot problem 
     c. High blood pressure                                          k. Arthritis 
      d. Back problem                                                    l. severe arthritis 
      e. Cataract or other vision disorder                  m. Other health problems 
 f. Osteoporosis    Specify ______________
  
 g. Parkinsons         
 h. Stroke 
3.  Are you currently limited in the type or amount of physical activity (work or 
leisure) you can do because of injury, illness or disability? 
     a. No 
      b. Yes, because of temporary illness (example: flu or fracture) 
           Please specify: __________________________ 
    c. Yes, because of long term illness, injury or disability (example: arthritis, 
diabetes, heart disease, back problem) Please specify: 
__________________________ 
4.  Has a physician ever said you have a heart condition and you should only 
do physical activity recommended by a physician?   
 a. Yes                                               b. No 
5.  When you are physically active, do you feel pain in your chest?  
      a. Yes                                               b. No 
6.  Do you ever lose you consciousness or do you lose your balance because 
of dizziness? 
      a. Yes                                               b. No 
7.  Do you have a joint or bone problem that may be made worse by a change 
in your physical activity? 
      a. Yes                                              b. No 
8.  Has your doctor ever told you that you should limit lifting or stair climbing? 
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      a. Yes                                               b. No 
9.  Has your physician prescribed medication for blood pressure or a heart 
condition? 
      a. Yes                                               b. No 
10. Are you currently enrolled in any other physical activity classes or groups? 
   a. No                                               
 b. Yes  What type: _____________________________ 
          Number of times per week: ________________ 
                                                                            
If you have answered yes to any of the above question, you may be 
required to obtain clearance from your doctor BEFORE you can volunteer 
for this study. We can assist you in this process. If you have answered no 
to all questions, you can be reasonably positive that you can safely 
participate without physical risk. However, if you are concerned, we 
encourage you to obtain clearance to participate from your physician.  
 
I have read these items carefully and answered all questions truthfully. 





Appendix C: Diabetes History 
Please answer the following questions honestly and to the best of your ability.  
 
1. What type of diabetes do you have? 
a. Type 1 




2. How long have you been diagnosed with diabetes?  _____________________ 
 
 
3. Do you currently take medications for diabetes treatment?       YES    /     NO 










Appendix D: Food Frequency Questionnaire 
Food Frequency Questionnaire – Please answer the questions about your diet over the 







Appendix E: Exercise Confidence Survey 
Below is a list of things people might do while trying to increase or continue regular exercise. We are 
interested in exercises like running, swimming, brisk walking, bicycle riding, or aerobics classes.  
 
Whether you exercise or not, please rate how confident you are that you could really motivate yourself to 
do things like these consistently, for at least six months.  
 
Please circle one number for each question.  
How sure are you that you can do these things?  
 
 I know I  Maybe I  I know I 
 Does not  
  cannot       can       can         
apply  
 
21.  Get up early, even on weekends, to exercise.  1  2  3  4  5  
 
22.  Stick to your exercise program after a long, tiring day  1  2  3  4  5   
 at work.  
 
23.  Exercise even though you are feeling depressed.  1  2  3  4  5  
 
24.  Set aside time for a physical activity program; that is,  1  2  3  4  5  
 walking, jogging. swimming, biking, or other continuous  
 activities for at least 30 minutes, 3 times per week.  
 
25.  Continue to exercise with others even though they  1  2  3  4  5   
 seem too fast or too slow for you.  
 
26.  Stick to your exercise program when undergoing a  1  2  3  4  5  
 stressful life change (e.g., divorce, death in the family,  
 moving).  
 
27.  Attend a party only after exercising.  1  2  3  4  5  
 
28.  Stick to your exercise program when your family is  1  2  3  4  5  
 demanding more time from you.  
 
29.  Stick to your exercise program when you have  1  2  3  4  5  
 household chores to attend to.  
 
30.  Stick to your exercise program even when you have  1  2  3  4  5  
 excessive demands at work.  
 
31.  Stick to your exercise program when social obligations  1  2  3  4  5 
 are very time consuming.  
  
32.  Read or study less in order to exercise more.  1  2  3  4  5  
Reference: Sallis JF, Pinski RB, Grossman RM, Patterson TL, Nader PR. The 
development of self-efficacy scales for health- related diet and exercise 
behaviors. Health Education Research. 1988;3(3):283. 
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Appendix F: Vigorous Walking Confidence Survey 
Below is a list of things people might do while trying to increase or continue vigorous walking. We are 
interested in planned and unplanned vigorous walking in bouts of at least 10 minutes.  
 
Whether you walk vigorously or not, please rate how confident you are that you could really motivate 
yourself to do things like these consistently, for at least six months.  
 
Please circle one number for each question.  
How sure are you that you can do these things?  
 
 I know I  Maybe I  I know I 
 Does not  
  cannot       can       can         
apply  
 
21.  Get up early, even on weekends, to walk vigorously.  1  2  3  4  5  
 
22.  Stick to your vigorous walking program after a long, tiring day  1  2  3  4  5   
 at work.  
 
23.  Walk vigorously even though you are feeling depressed.  1  2  3  4  5  
 
24.  Set aside time for a physical activity program; that is,  1  2  3  4  5  
 walking, jogging. swimming, biking, or other continuous  
 activities for at least 30 minutes, 3 times per week.  
 
25.  Continue to walk vigorously with others even though they  1  2  3  4  5  
 seem too fast or too slow for you.  
 
26.  Stick to your vigorous walking program when undergoing a  1  2  3  4  5  
 stressful life change (e.g., divorce, death in the family,  
 moving).  
 
27.  Attend a party only after walking vigorously.  1  2  3  4  5  
 
28.  Stick to your vigorous walking program when your family is  1  2  3  4  5  
 demanding more time from you.  
 
29.  Stick to your vigorous walking program when you have  1  2  3  4  5  
 household chores to attend to.  
 
30.  Stick to your vigorous walking program even when you have  1  2  3  4  5  
 excessive demands at work.  
 
31.  Stick to your vigorous walking program when social obligations  1  2  3  4  5  
 are very time consuming.  
  
32.  Read or study less in order to get more vigorous walking.  1  2  3  4  5 
 
Reference: Modified from Exercise Confidence Survey (Appendix E) 
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Appendix G: Sedentary Behavior Confidence Survey 
Below is a list of things people might do while trying to increase or continue taking breaks to interrupt 
sedentary time. We are interested in planned and unplanned breaks of at least 2 minutes for every half 
hour of sedentary time (i.e., sitting, watching TV, sitting in a vehicle, sitting at a desk or computer).  
 
Whether you interrupt your breaks or not, please rate how confident you are that you could really 
motivate yourself to do things like these consistently, for at least six months.  
 
Please circle one number for each question.  
How sure are you that you can do these things?  
 
 I know I  Maybe I  I know I 
 Does not  
  cannot       can       can         
apply  
 
21.  Interrupt sitting comfortably on the couch watching your 1  2  3  4  5   
 favorite TV show or movie to stand or take a break. 
 
22.  Stick to your plan to take a break every half hour, even during  1  2  3  4  5  
 a tiring day at work.  
 
23.  Get up and take a break even though you are feeling depressed.  1  2  3  4  5 
 
24.  Making a clear commitment to take a break in your sedentary   1  2  3  4  5  
 behavior (i.e., standing up, taking a walk, getting a drink, going  
 to the bathroom) for at least 2 minutes every half hour.   
 
25.  Continue to take a break every half hour even though your  1  2  3  4  5  
 friends never move from a sitting position all day.  
 
26.  Stick to your plan to get up every half hour when undergoing a  1  2  3  4  5  
 stressful life change (e.g., divorce, death in the family,  
 moving).  
 
27.  Do something fun only if you have taken breaks in your sitting  1  2  3  4  5  
 time throughout the day. 
 
28.  Stick to your plan to get up every half hour when your family   1  2  3  4  5  
 environment does not make it easy.  
 
29.  Stick to your plan to get up every half hour when you have  1  2  3  4  5  
 household chores that require you to sit.  
 
30.  Stick to your plan to take a break every half hour even when 1  2  3  4  5  
 you have excessive demands at work.  
 
31.  Stick to your plan of standing up and taking a break every half 1  2  3  4  5 
 hour when your friends or family are all sedentary.   
    
32.  Read or study less in order to take a break in your sedentary time.  1  2  3  4  5 
Reference: Modified from Exercise Confidence Survey (Appendix E) 
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Appendix H: IPAQ – Long Form 




LONG LAST 7 DAYS SELF-ADMINISTERED FORMAT 
 
FOR USE WITH YOUNG AND MIDDLE-AGED ADULTS (15-69 years) 
The International Physical Activity Questionnaires (IPAQ) comprises a set of 4 
questionnaires. Long (5 activity domains asked independently) and short (4 generic 
items) versions for use by either telephone or self-administered methods are available. 
The purpose of the questionnaires is to provide common instruments that can be used 
to obtain internationally comparable data on health–related physical activity. 
 
Background on IPAQ 
The development of an international measure for physical activity commenced in 
Geneva in 1998 and was followed by extensive reliability and validity testing 
undertaken across 12 countries (14 sites) during 2000. The final results suggest that 
these measures have acceptable measurement properties for use in many settings and 
in different languages, and are suitable for national population-based prevalence 
studies of participation in physical activity. 
 
Using IPAQ  
Use of the IPAQ instruments for monitoring and research purposes is encouraged. It is 
recommended that no changes be made to the order or wording of the questions as 
this will affect the psychometric properties of the instruments. 
Translation from English and Cultural Adaptation 
Translation from English is encouraged to facilitate worldwide use of IPAQ. Information 
on the availability of IPAQ in different languages can be obtained at www.ipaq.ki.se. If 
a new translation is undertaken we highly recommend using the prescribed back 
translation methods available on the IPAQ website. If possible please consider making 
your translated version of IPAQ available to others by contributing it to the IPAQ 
website. Further details on translation and cultural adaptation can be downloaded from 
the website. 
Further Developments of IPAQ  
International collaboration on IPAQ is on-going and an International Physical Activity 
Prevalence Study is in progress. For further information see the IPAQ website. 
More Information 
More detailed information on the IPAQ process and the research methods used in the 
development of IPAQ instruments is available at www.ipaq.ki.se and Booth, M.L. 
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(2000). Assessment of Physical Activity: An International Perspective. Research 
Quarterly for Exercise and Sport, 71 (2): s114-20. Other scientific publications and 
presentations on the use of IPAQ are summarized on the website. 
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
We are interested in finding out about the kinds of physical activities that people do as 
part of their everyday lives. The questions will ask you about the time you spent being 
physically active in the last 7 days. Please answer each question even if you do not 
consider yourself to be an active person. Please think about the activities you do at 
work, as part of your house and yard work, to get from place to place, and in your 
spare time for recreation, exercise or sport. 
Think about all the vigorous and moderate activities that you did in the last 7 days. 
Vigorous physical activities refer to activities that take hard physical effort and make 
you breathe much harder than normal. Moderate activities refer to activities that take 
moderate physical effort and make you breathe somewhat harder than normal. 
PART 1: JOB-RELATED PHYSICAL ACTIVITY 
 
The first section is about your work. This includes paid jobs, farming, volunteer work, 
course work, and any other unpaid work that you did outside your home. Do not 
include unpaid work you might do around your home, like housework, yard work, 
general maintenance, and caring for your family. These are asked in Part 3. 
1. Do you currently have a job or do any unpaid work outside your home? 
  Yes 
 No Skip to PART 2: TRANSPORTATION 
The next questions are about all the physical activity you did in the last 7 days as part 
of your paid or unpaid work. This does not include traveling to and from work. 
2.  During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, heavy construction, or climbing up stairs as 
part of your work? Think about only those physical activities that you did for at 
least 10 minutes at a time. 
_____ days per week 
  No vigorous job-related physical activity  Skip to question 4 
3. How much time did you usually spend on one of those days doing vigorous physical 
activities as part of your work? 
_____ hours per day 
_____ minutes per day 
4. Again, think about only those physical activities that you did for at least 10 minutes at 
a time. During the last 7 days, on how many days did you do moderate physical activities 
like carrying light loads as part of your work? Please do not include walking. 
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_____ days per week 
  No moderate job-related physical activity  Skip to question 6 
 
 5. How much time did you usually spend on one of those days doing moderate 
physical activities as part of your work? 
_____ hours per day 
_____ minutes per day 
6. During the last 7 days, on how many days did you walk for at least 10 minutes at a 
time as part of your work? Please do not count any walking you did to travel to or from 
work. 
_____ days per week 
 
 No job-related walking Skip to PART 2: TRANSPORTATION 
7. How much time did you usually spend on one of those days walking as part of your 
work? 
_____ hours per day 
_____ minutes per day 
 
PART 2: TRANSPORTATION PHYSICAL ACTIVITY 
 
These questions are about how you traveled from place to place, including to places 
like work, stores, movies, and so on. 
 
8. During the last 7 days, on how many days did you travel in a motor vehicle like a train, 
bus, car, or tram? 
_____ days per week 
 
 No traveling in a motor vehicle Skip to question 10 
9. How much time did you usually spend on one of those days traveling in a train, 
bus, car, tram, or other kind of motor vehicle? 
_____ hours per day 
_____ minutes per day 
Now think only about the bicycling and walking you might have done to travel to and 
from work, to do errands, or to go from place to place. 
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10. During the last 7 days, on how many days did you bicycle for at least 10 minutes at a 
time to go from place to place? 
_____ days per week 
 
 No bicycling from place to place Skip to question 12 
11. How much time did you usually spend on one of those days to bicycle from 
place to place? 
_____ hours per day 
_____ minutes per day 
12. During the last 7 days, on how many days did you walk for at least 10 minutes 
at a time to go from place to place? 
_____ days per week 
 
 No walking from place to place Skip to PART 3: 
HOUSEWORK, HOUSE 
MAINTENANCE, AND 
CARING FOR FAMILY 
13. How much time did you usually spend on one of those days walking from place to 
place? 
_____ hours per day 
_____ minutes per day 
 
PART 3: HOUSEWORK, HOUSE MAINTENANCE, AND CARING FOR FAMILY 
This section is about some of the physical activities you might have done in the last 7 
days in and around your home, like housework, gardening, yard work, general 
maintenance work, and caring for your family. 
 
14. Think about only those physical activities that you did for at least 10 minutes at a time. 
During the last 7 days, on how many days did you do vigorous physical activities like heavy 
lifting, chopping wood, shoveling snow, or digging in the garden or yard? 
_____ days per week 
 
 No vigorous activity in garden or yard Skip to question 16 
15. How much time did you usually spend on one of those days doing vigorous physical 
activities in the garden or yard? 
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_____ hours per day 
_____ minutes per day 
16. Again, think about only those physical activities that you did for at least 10 minutes at 
a time. During the last 7 days, on how many days did you do moderate activities like 
carrying light loads, sweeping, washing windows, and raking in the garden or yard? 
_____ days per week 
  No moderate activity in garden or yard Skip to question 18 
17. How much time did you usually spend on one of those days doing moderate physical 
activities in the garden or yard? 
_____ hours per day 
_____ minutes per day 
18. Once again, think about only those physical activities that you did for at least 10 
minutes at a time. During the last 7 days, on how many days did you do moderate 
activities like carrying light loads, washing windows, scrubbing floors and sweeping inside 
your home? 
_____ days per week 
 




19. How much time did you usually spend on one of those days doing moderate physical 
activities inside your home? 
_____ hours per day 
_____ minutes per day 
 
PART 4: RECREATION, SPORT, AND LEISURE-TIME PHYSICAL ACTIVITY 
This section is about all the physical activities that you did in the last 7 days solely for 
recreation, sport, exercise or leisure. Please do not include any activities you have already 
mentioned. 
20. Not counting any walking you have already mentioned, during the last 7 days, on how 
many days did you walk for at least 10 minutes at a time in your leisure time? 
_____ days per week 
 
 No walking in leisure time Skip to question 22 
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21. How much time did you usually spend on one of those days walking in your leisure 
time? 
_____ hours per day 
_____ minutes per day 
22. Think about only those physical activities that you did for at least 10 minutes at a time. 
During the last 7 days, on how many days did you do vigorous physical activities like 
aerobics, running, fast bicycling, or fast swimming in your leisure time? 
_____ days per week 
 
 No vigorous activity in leisure time Skip to question 24 
 
23. How much time did you usually spend on one of those days doing vigorous physical 
activities in your leisure time? 
_____ hours per day 
_____ minutes per day 
 
24. Again, think about only those physical activities that you did for at least 10 minutes at 
a time. During the last 7 days, on how many days did you do moderate physical activities 
like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your 
leisure time? 
_____ days per week 
 
 No moderate activity in leisure time Skip to PART 5: TIME 
SPENT SITTING 
25. How much time did you usually spend on one of those days doing moderate physical 
activities in your leisure time? 
_____ hours per day 
_____ minutes per day 
 
PART 5: TIME SPENT SITTING 
The last questions are about the time you spend sitting while at work, at home, while doing 
course work and during leisure time. This may include time spent sitting at a desk, visiting 
friends, reading or sitting or lying down to watch television. Do not include any time spent 
sitting in a motor vehicle that you have already told me about. 
26. During the last 7 days, how much time did you usually spend sitting on a weekday? 
_____ hours per day 
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_____ minutes per day 
 
27. During the last 7 days, how much time did you usually spend sitting on a weekend 
day? 
_____ hours per day 
_____ minutes per day 
 





















Appendix K: Weekly Emails 
Walking-Only E-mails 
*Emails were piloted during two 8-week walking programs for adults at risk for type II 
diabetes and cardiovascular disease. 
Week 1 
Hello___________!  
As part of the walking program you are participating in, you will be receiving weekly 
emails from me.  I hope you will be able to use the tips I include each week.  Thank you 
so much for your participation! Have a great week and don’t forget to fill out your 
Activity Log this week! 
 
 Physical Activity: It can be helpful to set goals about choosing physical activity 
instead of another activity (like watching TV). An example would be to set a 
goal of substituting a short walk for your least favorite TV show. It may be 
helpful to set a specific time and/or a place each day that you are able to walk.  
 
What strategy could you use next week to be successful in reaching your walking 
goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 






I hope your week went well last week. Make sure you turn in the Activity Log each 
week as soon as you finish every Sunday. Just a reminder, don’t forget to fill out your 
Activity Log this week! 
 Physical Activity: When you are trying to achieve your weekly goals for 
walking time, choose a specific time that you feel confident that you can achieve 
but try to make an improvement from what you are doing now to reach the 
specified goal. Remember, the overall goal is to get 10,000 steps per day as soon 
as possible.  
 
Were you successful in achieving last week’s goal? 
 
Unsuccessful 1 2 3 4 5 Successful 
 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
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Please e-mail your response back to me as soon as you are able. Thank you so much for 






I hope your week is going well, and don’t forget to fill out your Step Log this week! 
Here is the tip for this week: 
 Reward: When you reach your daily goal for walking this week, choose a small 
reward for yourself that you will do or get if you achieve your goal every day. 
The reward can be something that you go buy like that book you have been 
wanting to read or something that is free like a nice bubble bath.  
 
Were you successful in achieving last week’s goal? 
Unsuccessful 1 2 3 4 5 Successful 
 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 






 I hope your week is going well so far (especially if you have Spring break). Make sure 
you turn in the Step Log from last week if you haven’t! Have a great week and don’t 
forget to fill out your log this week! I will likely be calling on Monday of next week 
because many are out of the office this week. 
 Physical Activity: Remember to be getting those steps in EVERY DAY! Keep 
on improving! Invite a friend or family member on a walk with you. It will give 
you somebody to talk to. Who knows, it may become a routine for both of you! 
 Were you successful in achieving last week’s goal? 
Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
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Please e-mail your response back to me as soon as you are able. Thank you so much for 




I hope your week is going well! Make sure you turn in the Activity Log from last week 
if you haven’t already done so. Have a great week and don’t forget to fill out your 
Activity Log this week! 
 Physical Activity: You have passed the four-week mark and are still working 
hard! When the weeks get difficult and you don’t think you can finish, look at 
your past weeks and remember your best week yet! Keep moving no matter 
what! Any progress is good progress! 
 
Were you successful in achieving last week’s goal? 
Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
 
Please e-mail your response back to me as soon as you are able. Thank you so much for 
your participation! Have a wonderful week!  
REMINDER: At the end of week 6  (next week) I will email everyone and will be 
passing out the accelerometers for our mid-test measure which will take place 






I hope this week is going well and you are looking forward to nice weather this 
weekend! Make sure you turn in the Activity Log from last week if you haven’t yet. 
Have a great rest of the week! 
 
 Physical Activity: Look at how far you have come! You have gone for half of 
the program now and are still doing GREAT! Keep sticking with your walking 
just as you have been doing for the past month! Keep up the good work!  
 Remember: Any improvement is good!! 
 
Were you successful in achieving last week’s goal? 
Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
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Please e-mail your response back to me as soon as you are able. Thank you so much for 









I hope your week is going awesome now that the weather is nice. Make sure you turn in 
the Activity Log from last week if you haven’t already. 
Here is your tip for the week: 
 Physical Activity: Don’t compare your walking to other people.  Instead, 
compete with yourself.  Do better this week than you did last week.  Do better 
today than you did yesterday! Any progress is good! 
 
Were you successful in achieving last week’s goal? 
Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 







Thanks for wearing the accelerometers again! I hope your week is going well this week. 
Make sure you turn in the Activity Log from last week if you haven’t yet. Have a great 
week and don’t forget to fill out your Activity Log this week! 
 
 Physical Activity: Although walking is considered such a great form of exercise 
due to its ease and flexibility, any exercise program is difficult to begin and 
maintain. Even if you aren’t as active as you would like to be, you are still 
reading the emails. That means you are still headed in the right direction. You 
have accomplished something great by starting this program and I encourage 
you to keep pushing forward! 
 
Were you successful in achieving last week’s goal? 
Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
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Please e-mail your response back to me as soon as you are able. Thank you so much for 







I hope your week is going great! A quick reminder to turn in the Activity Log from last 
week if you haven’t already. 
Here is your tip for the week: 
 Physical Activity: Think ahead as this program nears the end.  Schedule your 
walking into your day and set goals for when you have walked 3, 5, 10 or even 
20 days in a row. Then you can look back and see your successes and see your 
habit forming. 
 
Were you successful in achieving last week’s goal? 
Unsuccessful 1 2 3 4 5 Successful 
 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 





Good Afternoon Everyone! 
I hope your week is going wonderfully. Make sure you turn in the Activity Log from 
last week if you haven’t already. Just a quick thought for today, 
 Physical Activity: Remember, don’t compare your walking to other people.  
Instead, compete with yourself.  
 
Were you successful in achieving last week’s goal? 
Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 








It was great to talk to all of yall these last couple days! I hope your week is going 
wonderfully. Make sure you turn in the Activity Log from last week if you haven’t 
already. Just a quick thought for today, 
 Physical Activity: You are now about to start your last week and you have 
accomplished something great.  Even though you may or may not have achieved 
the goals you set in the beginning, you are still reading these emails, which 
means you still care about your fitness journey! Remember that long-term 
change is usually a slow process done with small, consistent steps in the right 
direction.  
Were you successful in achieving last week’s goal? 
Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 







I hope your final week is going well! Make sure you turn in the Activity Log from last 
week if you haven’t already. Here is a thought for this week and a couple reminders: 
 Physical Activity: Although walking is considered such a great form of exercise 
due to its ease and flexibility, any exercise program is difficult to begin and 
maintain. I say, you have accomplished something great by starting this program 
and I encourage you to continue your journey! 
 Remember to wear the accelerometer each day through Sunday (at least 
10hrs/day for it to count) 
 Blood draws next week (I’ll send another reminder the day before) and that 
is where you will bring the accelerometer 
 Remember to finish the surveys this weekend if you can 
 
Were you successful in achieving last week’s goal? 
Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 






Appendix L: Weekly Emails 
Breaks Only E-mails 
 





As part of the walking program you are participating in, you will be receiving weekly 
emails from me.  I hope you will be able to use the tips I include each week.  Thank you 
so much for your participation! Just a reminder, don’t forget to fill out your Walk Log 
this week! 
Here is your tip for this week! 
 It could be helpful to use a device such as a timer or watch to beep once an hour 
as you are sitting at work or at home to remind you to get up and take a 2 minute 
walk. 
What strategy could you use next week to be successful in reaching your goal to 
reduce sitting time?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 






I hope your week went well last week. Make sure you turn in the Activity Log each 
week as soon as you finish every Sunday. Just a reminder, don’t forget to fill out your 
Activity Log this week! 
Here are your tips for this week! 
     Computer Use: When you are using the computer at work, try setting an alarm to 
remind you to move after a specified period of time. At home, you can also start a load 
of laundry so that you have to get up periodically while working at the computer. It is 
also helpful to avoid playing games on computer for a long time. Do the best you can! 
Were you successful at taking breaks every half hour of sedentary time? 
Unsuccessful 1 2 3 4 5 Successful 
 If successful, what strategies did you use to reach your goal? 
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 If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 






I hope your week is going well so far, and don’t forget to fill out your Walk Log this 
week! 
Here is your tip for this week!  
 
 Reading: When you are sitting reading, try standing up and walking after you 
have finished a chapter or a section of the newspaper.  
Were you successful at taking breaks every hour of sedentary time? 
Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 





I hope your week is going well! Make sure you turn in the Log from last week if you 
haven’t, and don’t forget to fill out your Activity Log this week! I will likely be calling 
on Monday of next week because many are out of the office this week. 
 
Here are your tips for this week! 
 
 Socializing: When socializing, stand up and get refreshments for others instead 
of waiting for them to serve you. Tell your friends and family as well about the 
study so they can remind you to get up and move. Try walking while talking on 
the telephone. It could also be better to walk to visit coworkers’ desks instead of 
calling them on the telephone. 
Were you successful at taking breaks every half hour of sedentary time? 
Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
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Please e-mail your response back to me as soon as you are able. Thank you so much for 






I hope your week is going well! Make sure you turn in the Activity Log from last week 
if you haven’t done so already. Just a reminder, don’t forget to fill out your Activity 
Log this week! 
Here are your tips for this week! 
 Physical Activity: You have passed the four-week mark and are still working 
hard! When the weeks get difficult and you don’t think you can finish, look at 
your past weeks and remember your best week yet! Keep moving no matter 
what! Any progress is good progress! 
 
 Hobbies: When you are busy having fun with puzzles or doing crafts like 
cutting fabric for quilting or if you are sitting at an easel to paint, try interrupting 
these hobbies by standing up and moving around. When listening to music, try 
walking around or dancing. Just make it a habit! 
 
Were you successful at taking breaks every half hour of sedentary time? 
Unsuccessful 1 2 3 4 5 Successful 
 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 
your participation! Have a wonderful week!  
REMINDER: At the end of week 6  (next week) I will email everyone and will be 
passing out the accelerometers for our mid-test measure which will take place 





I hope this week is going well and you are looking forward to nice weather this 
weekend! Make sure you turn in the Activity Log from last week if you haven’t yet. 
Have a great rest of the week! 
Here are your tips for this week! 
 Physical Activity: Look at how far you have come! You have completed half of 
the program now and are still doing GREAT! Keep sticking with your walking 
just as you have been doing for the past 6 weeks! Keep up the good work! 
 Remember: Any improvement is good!! 
Were you successful at taking breaks every half hour of sedentary time? 
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Unsuccessful 1 2 3 4 5 Successful 
 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 







I hope your week is going awesome now that the weather is nice. Make sure you turn in 
the Activity Log from last week if you haven’t already. 
Here are your tips for this week! 
 Household Activities: When doing household chores, try splitting-up these 
chores and extending the time it takes to complete each task to allow for more 
breaks (e.g., put away each item of ironing after completion, doing small parts 
of cleaning in segments). Try also using your free time to do the chores that you 
have been avoiding (e.g., walking to deliver or pick up something).  
Were you successful at taking breaks every half hour of sedentary time? 
Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 






Thanks for wearing the accelerometers again! I hope your week is going well this week. 
Make sure you turn in the Activity Log from last week if you haven’t yet. Have a great 
week and don’t forget to fill out your Activity Log this week! 
Here are your tips for this week! 
 Although walking is considered such a great form of exercise due to its ease and 
flexibility, any exercise program is difficult to begin and maintain. Even if you 
aren’t as active as you would like to be, you are still reading the emails. That 
means you are still headed in the right direction. You have accomplished 
something great by starting this program and I encourage you to keep pushing 
forward! 
 
Were you successful at taking breaks every half hour of sedentary time? 
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Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 






I hope your week is going great! A quick reminder to turn in the Activity Log from last 
week if you haven’t already. 
Here is your tip for the week: 
 Goal Setting: Think ahead as this program nears the end.  Schedule your breaks 
into your day as much as you can and set goals for when you have reached a 
certain number of breaks on 3, 5, 10 or even 20 days in a row. Then you can 
look back and see your past successes and see your habit forming.  
 
Were you successful in achieving last week’s goal? 
Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 






Good Afternoon Everyone! 
I hope your week is going wonderfully. Make sure you turn in the Activity Log from 
last week if you haven’t already. Just a quick thought for today, 
 Breaks: Remember, don’t compare how active you are to other people.  Instead, 
compete with yourself.  
 
Were you successful in achieving last week’s goal? 
Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 







It was great to talk to all of ya’ll these last couple days! I hope your week is going 
wonderfully. Make sure you turn in the Activity Log from last week if you haven’t 
already. Just a quick thought for today, 
 Breaks: You are now about to start your last week and you have accomplished 
something great.  Even though you may or may not have achieved the goals you 
set in the beginning, you are still reading these emails, which means you still 
care about your fitness journey! Remember that long-term change is usually a 
slow process done with small, consistent steps in the right direction.  
 
Were you successful in achieving last week’s goal? 
Unsuccessful 1 2 3 4 5 Successful 
 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 







I hope your final week is going well! Make sure you turn in the Activity Log from last 
week if you haven’t already. Here is a thought for this week and a couple reminders: 
 Physical Activity: Although walking is considered such a great form of exercise 
due to its ease and flexibility, any exercise program is difficult to begin and 
maintain. I say, you have accomplished something great by starting this program 
and I encourage you to continue your journey! 
 Remember to wear the accelerometer each day through Sunday (at least 
10hrs/day for it to count) 
 Blood draws next week (I’ll send another reminder the day before) and that 
is where you will bring the accelerometer 
 Remember to finish the surveys this weekend if you can 
 
Were you successful in achieving last week’s goal? 
Unsuccessful 1 2 3 4 5 Successful 
If successful, what strategies did you use to reach your goal? 
If unsuccessful, what strategy could you use next week to be more successful in 
reaching your walking goal?  
Please e-mail your response back to me as soon as you are able. Thank you so much for 
your participation! See you next week!  
Merrill Funk  
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Appendix M 
Accelerometer average moderate/vigorous minutes of PA per day 
Shaded regions were included in analysis.  
Group assignment: WG=Walking Group, BG=Breaks Group. 




















1 63    
2BG 11 13 28 18 
3BG 12 9 12 7 
4WG 32 75 83 48 
5WG 15 27 12 15 
6WG  12 13  
7WG 12 19 15 12 
8BG     
9     
10BG     
11BG 7 10 10 49 
12WG 21 32   
13BG 32   65 
14BG 29    
15BG 42 40 53 61 
16BG 17 16 37 33 
17BG 8 13 6 5 
18WG 8 20 12 3 
19WG  9   
20     
21WG 16 45 30 35 
22WG 13 65 95 15 
Walking Mean 
(SD) 
16.0 (8.3) 41.8 (23.9) 41.2 (37.8) 21.3 (16.7) 
Breaks Mean 
(SD) 
16.17 (13.1) 16.8 (11.6) 24.3 (18.4) 28.8 (22.9) 
Combined 
Mean (SD) 















































* Significant pre- 





































* Significant pre- 
post- time effect 
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Appendix N 
Average pedometer step counts during measurement periods 
Shaded regions were included in analysis.  
Group assignment: WG=Walking Group, BG=Breaks Group.  
Dark shaded regions represent baseline value (for participant 6) and mid value (for 



















1     
2BG 4698 4224 2857 6248 
3BG 4386 4454 4522 3679 
4WG 6362   6459 
5WG 6199    
6WG 1474 902 1914 1474 
7WG 3981 6155 2185 1774 
8BG 8306    
9     
10BG     
11BG 4222  3365 9232 
12WG 5446 5231   
13BG 3881  3302 2471 
14BG     
15BG 6981  9880 6225 
16BG 2531 988 2852 2688 
17BG 4780  11051 3719 
18WG 4375   1933 
19WG     
20     
21WG 2035 5695 5695 3563 
22WG 5236 8702 17931 2907 
Walking Mean 
(SD) 
3181.5 (1740.7)  6931.3 (7532.7) 2429.5 (975.6) 
Breaks Mean 
(SD) 
4497.0 (1330.6)  5404.1 (3518.5) 4894.6 (2450.1) 
Combined 
Mean (SD) 



































































































4 6889 8511 8663 8661 9753 9932  10177 10716 10812   
5 8999 9166 10478 10069         
6 2372 2647 2756 1903 2394 1522 2309 1619 2179 1621 2368  
7 4714 4941 7633 7170 6328 5705 6155 7495 8762    
12 3628 4788 4163 4425 4245 3890 5246  3287   1914 
18 5113 5113       6292 5475 6271  
21 2943 5554 4474 3651 5876 5891 5695 5670 5060 5814 5153  
22  8843 12883 10763 11925 9600 8702 12514 13418 12992 14378 17931 
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Appendix P 







1 548  
2BG 180 673 
3BG 424 585 
4WG 330 924 
5WG 450 840 
6WG  1968 
7WG 60  
8BG   
9   
10BG 10805  
11BG 180 960 
12WG 3358 11184 
13BG 23495 18120 
14BG 594  
15BG 582 1943 
16BG 975 7740 
17BG 945  
18WG 855 28860 
19WG 270  
20   
21WG 453 778 
22WG 2580 40135 
Walking Mean 
(SD) 
1337.7 (1299.5) 13786.8 (16914.5) 
Breaks Mean 
(SD) 
4305.9 (9405.1) 5003.5 (6978.9) 
Combined 
Mean (SD) 
2821.8 (6586.2) 9395.2 (13161.5) 
Shaded regions were included in analysis.  
Group assignment: WG=Walking Group, BG=Breaks Group. 
About 500 MET-minutes per week is equal to 30 minutes of walking or higher intensity 
activity on 5 days per week. (walking = 3.3METs, moderate activity = 4.0METs, 













































































Accelerometer sedentary hours (average per day) 
Shaded regions were included in analysis.  
Group assignment: WG=Walking Group, BG=Breaks Group.  




















1 10.6    
2BG 13.1 11.7 12.4 11.8 
3BG 12.0 11.0 11.4 10.2 
4WG 9.9 8.9 9.1 9.7 
5WG 12.7 12.9 12.2 12.7 
6WG  9.6 9.8  
7WG 12.8 11.9 10.5 12.8 
8BG     
9     
10BG     
11BG 9.9 12.5 11.5 10.4 
12WG 9.4 9.0   
13BG 9.9   9.8 
14BG 9.5    
15BG 12.7 11.0 11.0 9.9 
16BG 12.2 11.6 12.6 10.5 
17BG 11.7 11.2 10.7 10.1 
18WG 10.3 9.1 10.4 10.0 
19WG  12.5   
20     
21WG 10.8 11.8 12.5 11.3 
22WG 11.5 10.4 8.7 11.2 
Walking Mean 
(SD) 
11.3 (1.2) 10.8 (1.6) 10.6 (1.6) 11.3 (1.3) 
Breaks Mean 
(SD) 
11.9 (1.1) 11.5 (0.57) 11.6 (0.76) 10.5 (0.68) 
Combined 
Mean (SD) 























































































1 8.9  
2BG 12.5 12.4 
3BG 12.1 10.1 
4WG 7.3 6.6 
5WG 11.4 6.4 
6WG 8.0 8.0 
7WG 7.9  
8BG 13.1  
9   
10BG 2.6  
11BG 10.0 8.9 
12WG 7.9 7.4 
13BG 6.9 5.1 
14BG 6.3  
15BG 10.0 7.7 
16BG 11.6 5.7 
17BG 9.0  
18WG 3.4 3.7 
19WG 4.0  
20   
21WG 10.3 5.0 
22WG 12.0 20.0 
Walking Mean 
(SD) 
8.6 (2.9) 8.2 (5.4) 
Breaks Mean 
(SD) 
10.5 (2.1) 8.3 (2.7) 
Combined 
Mean (SD) 
9.5 (2.7) 8.2 (4.2) 
Shaded regions were included in analysis.  




























































































1 5    
2BG 9 5 6 6 
3BG 8 8 7 7 
4WG 3 3 4 3 
5WG 7 6 6 7 
6WG  1 4  
7WG 8 4 6 8 
8BG     
9     
10BG     
11BG 5 7 6 4 
12WG 5 5   
13BG 4   5 
14BG 1    
15BG 5 4 5 3 
16BG 5 5 6 4 
17BG 7 5 6 6 
18WG 4 3 4 2 
19WG  6   
20     
21WG 5 4 3 4 
22WG 3 4 3 6 
Walking Mean 
(SD) 
5.0 (2.1) 4.0 (1.1) 4.3 (1.4) 5.0 (2.4) 
Breaks Mean 
(SD) 
6.5 (1.8) 5.7 (1.5) 6.0 (0.63) 5.0 (1.5) 
Combined 
Mean (SD) 
5.8 (2.0) 4.8 (1.5) 5.2 (1.3) 5.0 (1.9) 
Shaded regions were included in analysis.  
Group assignment: WG=Walking Group, BG=Breaks Group.  

















































































1 3.0  
2BG 4.2  
3BG 4.9 3.1 
4WG 4.9 4.8 
5WG 4.6  
6WG 4.8 2.8 
7WG 3.9  
8BG 3.5  
9   
10BG 4.0  
11BG 4.7 4.6 
12WG 4.0  
13BG 5.0 5.0 
14BG 4.0  
15BG 4.9  
16BG 5.0 3.5 
17BG 4.6  
18WG 4.0 4.8 
19WG 4.7  
20   
21WG 4.5 4.1 
22WG 4.0 4.8 
Walking Mean 
(SD) 
4.4 (0.43) 4.3 (0.86) 
Breaks Mean 
(SD) 
4.9 (0.14) 4.1 (0.89) 
Combined 
Mean (SD) 
4.6 (0.40) 4.2 (0.82) 
Shaded regions were included in analysis.  













































































1 3.1  
2BG 4.3 4.4 
3BG 4.9 3.5 
4WG 4.9 4.8 
5WG 4.7 2.8 
6WG 4.7 2.8 
7WG 3.8  
8BG 3.8  
9   
10BG 5.0  
11BG 4.8 4.4 
12WG 3.9  
13BG  5.0 
14BG 4.8  
15BG 4.7  
16BG 4.9 3.5 
17BG 4.2  
18WG 4.0 4.6 
19WG 4.8  
20   
21WG 4.3 3.9 
22WG 4.0 4.0 
Walking Mean 
(SD) 
4.4 (0.39) 3.8 (0.85) 
Breaks Mean 
(SD) 
4.7 (0.29) 3.9 (0.54) 
Combined 
Mean (SD) 
4.6 (0.37) 3.9 (0.71) 
Shaded regions were included in analysis.  

















































































1 3.3  
2BG 4.8 4.5 
3BG 4.9 3.6 
4WG 5.0 4.8 
5WG 4.8 3.1 
6WG 4.8 3.5 
7WG 4.3  
8BG 5.0  
9   
10BG 4.7  
11BG 4.8 3.9 
12WG 3.7  
13BG 5.0 5.0 
14BG 4.8  
15BG 4.8  
16BG 4.9 3.9 
17BG 4.5  
18WG 4.0 3.8 
19WG 3.4  
20   
21WG 3.8 3.8 
22WG 4.0 4.0 
Walking Mean 
(SD) 
4.4 (0.52) 3.8 (0.56) 
Breaks Mean 
(SD) 
4.9 (0.08) 4.2 (0.56) 
Combined 
Mean (SD) 
4.6 (0.45) 4.0 (0.56) 
Shaded regions were included in analysis.  
















































Sedentary Break Self-Efficacy 
WG
BG
* Significant pre- 





























Sedentary Break Self-Efficacy 
WG
BG
* Significant pre- 
post- time effect * 
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Appendix W 









1    
2BG 82 83 88 
3BG 137 119 162 
4WG 134  112 
5WG 88 114  
6WG 111 117  
7WG 142 136 134 
8BG 138   
9    
10BG 242   
11BG 213 198 168 
12WG 170 162  
13BG 250 260 164 
14BG 158   
15BG 89 109  
16BG 187 154 171 
17BG 125 142 121 
18WG 162  129 
19WG 113   
20 258   
21WG 93 98 96 
22WG 174 120 122 
Walking Mean 
(SD) 
129.7 (37.9) 124.5 (22.0) 117.3 (19.4) 
Breaks Mean 
(SD) 
154.7 (63.7) 152.1 (60.0) 145.7 (33.7) 
Combined 
Mean (SD) 
143.2 (52.9) 139.4 (47.0) 136.2 (31.7) 
Shaded regions were included in analysis.  














































































1    
2BG 10.4 5.8 5.8 
3BG 5.2 6.5 7.8 
4WG 6.1  5.8 
5WG 8.2 5.8  
6WG 10.4 6.2  
7WG 6.2 6.6 6.4 
8BG 7.9   
9    
10BG 10.6   
11BG 9.6 6 9.4 
12WG 9.2 8.5  
13BG 13 10.8 10.7 
14BG 5   
15BG 5.8 6  
16BG 7.5 8 8.3 
17BG 10.2 6 8 
18WG 6.7 2 8.1 
19WG 6.1   
20 13   
21WG 5.3 5.9 6.4 
22WG 6.7 8.2 9.1 
Walking Mean 
(SD) 
7.5 (1.8) 6.2 (2.1) 7.5 (1.3) 
Breaks Mean 
(SD) 
8.8 (2.8) 7.0 (1.8) 8.3 (1.6) 
Combined 
Mean (SD) 
8.2 (2.4) 6.6 (2.0) 8.0 (1.5) 
Shaded regions were included in analysis.  















































* Significant pre- 
























* Significant pre- 













1    
2BG 4.5 3.2 3.1 
3BG 4.6 5.7 3.8 
4WG 3.4  3.7 
5WG 3 3.7  
6WG 4.3 4.2  
7WG 4.7 5.1 3.4 
8BG 3.2   
9    
10BG 5.7   
11BG 3 3.1 3.3 
12WG 4.2 5.7  
13BG 5.2 6.3 5.8 
14BG 3.1   
15BG 3.7 3.9  
16BG 3.2 4.1  
17BG 2.6 3.6 4.3 
18WG 5.4  5.9 
19WG 3.7   
20 2.5   
21WG 3.2 2.6 2.5 
22WG 4.1 4.3 3.4 
Walking Mean 
(SD) 
3.9 (0.67) 4.3 (1.1) 3.1 (0.50) 
Breaks Mean 
(SD) 
3.8 (0.96) 4.3 (1.2) 4.0 (1.1) 
Combined 
Mean (SD) 
3.9 (0.81) 4.3 (1.1) 3.7 (0.98) 
Shaded regions were included in analysis.  





















































































Cholesterol Ratio (Total/HDL) 
WG
BG
